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ABSTRACT 
 
Severe maternal morbidity generally refers to the most severe complications of 
pregnancy and includes: hemorrhage, embolism, acute renal failure, stroke, acute myocardial 
infarction, and other complications. These complications affect more than 50,000 women in the 
United States every year, with rates significantly increasing from 1998 to 2011. In an effort to 
reduce these increasing complication rates, clinicians and researchers have emphasized the need 
to identify potential modifiable risk factors for severe maternal morbidity, and the need to study 
the relationships between these risk factors and severe maternal morbidity. The overall goal of 
this study is to improve the understanding of the increasing rates of severe maternal morbidity. 
The objective of the first study is to examine the association between prepregnancy BMI 
and severe maternal morbidity in women residing in Florida who had a live birth during 2007-
2014. Additionally, the specific association between prepregnancy BMI and the most common 
individual conditions that comprise the composite measure of severe maternal morbidity will 
also be examined. We conducted a population-based retrospective cohort study using Florida’s 
linked birth certificate and maternal hospital discharge data for the years 2007-2014. The risk of 
severe maternal morbidity associated with BMI was then estimated by odds ratios (OR) and 95% 
confidence intervals (CI) derived using generalized estimating equations (GEE) for logistic 
regression. This final model was rerun separately for the most common conditions that comprise 
severe maternal morbidity as the outcome measure to assess differences by type of condition. 
Unadjusted rates of severe maternal morbidity increased with increasing BMI; however, after 
risk adjustment overweight and obese women had slightly protective odds of severe maternal 
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morbidity when compared with normal weight women. The association between prepregnancy 
BMI and severe maternal morbidity differs by types of severe maternal morbidity. A protective 
dose-response relationship was seen for blood transfusion and disseminated intravascular 
coagulation, with the odds of morbidity decreasing with increasing BMI. The odds of heart 
failure, adult respiratory distress syndrome, and ventilation all increased with increasing BMI. 
This study shows that severe maternal morbidity is a complex measure and not just a single 
condition. In future studies, it will be imperative to analyze severe maternal morbidity as a 
composite measure and as individual conditions to identify modifiable risk factors to focus on for 
interventions. 
The objective of the second study is to identify potential determinants of the increase in 
the rate of severe maternal morbidity among women residing in Florida who had a live birth 
during 2005-2014. We examined severe maternal morbidity rates and related risk factors in live 
births to Florida women between 2005 and 2014, using Florida’s linked birth certificate and 
hospital discharge data. We initially conducted a Kitagawa analysis to evaluate the components 
of the increased rate of severe maternal morbidity between 2005 and 2014. Additionally, we 
performed a multivariable regression analysis to estimate the contribution of the multiple factors 
to differences in the rate of severe maternal morbidity in 2005 and 2014. The rate of severe 
maternal morbidity in 2014 was 19.3 per 1,000 live births, which was 1.65 times higher than the 
rate in 2005. Nearly all of the excess severe maternal morbidity and blood transfusions in 2014 
can be explained by differences in the rate of severe maternal morbidity and blood transfusion 
between the two time periods. In total, sociodemographic factors, medical factors, and individual 
and hospital health service factors explained 9.1% of the overall severe maternal morbidity 
increase in 2014 compared with 2005, and only explained 2.5% of the increase in blood 
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transfusions during this time period. Our study findings indicate that the increase in the rate of 
severe maternal morbidity is comprised almost entirely by an increase in the rate of blood 
transfusions. Further research will need to be conducted to explain the increase in the rate of 
severe maternal morbidity and blood transfusions. 
Consistent with national trends, the rates of severe maternal morbidity have been 
increasing in Florida. This increase is driven almost entirely by blood transfusions and cannot be 
explained by traditional factors that are readily available in current datasets. In addition to the 
differences between the trends of blood transfusions and the 20 severe maternal morbidity 
conditions, there are also differences in risk factors associated with these different conditions. 
Prepregnancy overweight and obesity is associated with a protective effect with blood 
transfusions and disseminated intravascular coagulation that is not seen in the other conditions. 
Therefore, initiatives to decrease the rates of severe maternal morbidity will need to take these 
differences into account. 
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INTRODUCTION AND SPECIFIC AIMS 
 
Significance and Justification 
Childbirth is the most common reason for hospitalization in the United States, with more 
than four million births each year.1 During pregnancy and childbirth, some women experience 
maternal morbidity, defined as physical and psychological conditions that result from or are 
aggravated by pregnancy and have an adverse effect on a woman’s health.2 Severe maternal 
morbidity generally refers to the most severe complications of pregnancy and includes: 
hemorrhage, embolism, acute renal failure, stroke, acute myocardial infarction, and other 
complications. These complications affect more than 50,000 women in the United States every 
year,3 with rates significantly increasing from 1998 to 2011.2 The rate of severe maternal 
morbidity has also increased in Florida, with the rate increasing from 9.2 complications per 
1,000 live births in 2004 to 20.9 complications per 1,000 live births in 2014.4 Similar to the 
national findings, the rates of complications in Florida were highest for blood transfusion (an 
indirect measure for hemorrhage), disseminated intravascular coagulation, and heart failure 
during a procedure or surgery.4 
While severe maternal morbidity occurs in roughly two percent of births, when applied to 
a large cohort of birthing women, these conditions often result in potential mortality, high direct 
medical cost, extended length of hospitalization, and long-term rehabilitation.3 In response to 
these concerns, there has been a call for an organized national approach to reduce maternal 
morbidity and mortality in the United States.5 
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In an effort to reduce these increasing complication rates, clinicians and researchers have 
emphasized the need to identify potential modifiable risk factors for severe maternal morbidity, 
and the need to study the relationships between these risk factors and severe maternal 
morbidity.5,6 For example, obesity rates and severe maternal morbidity rates have increased 
dramatically over the past decade and researchers have speculated that there is a casual 
relationship between obesity and severe maternal morbidity. However, the exact relationship 
between these two factors is not clearly evident. The lack of evidence suggests that further 
research needs to be conducted in order to determine the true relationship between maternal 
obesity and severe maternal morbidity, and to identify modifiable risk factors and prevention 
opportunities. Additionally, despite the increasing rates of severe maternal morbidity, a formal 
analysis attempting to quantify the causes of the increase in the rates of severe maternal 
morbidity has not been conducted. In order to fully combat the increasing rates of these 
conditions, further research needs to be conducted to identify the specific causes of the 
increasing rate. 
Specific Aims and Research Questions 
The overall goal of this study is to improve the understanding of the increasing rates of 
severe maternal morbidity. This will be done by first examining the association between a 
specific risk factor for severe maternal morbidity and then by examining the contribution of 
various risk factors to the increased rate of severe maternal morbidity. First, this will be 
accomplished by improving the understanding of the relationship between pre-pregnancy obesity 
and severe maternal morbidity. Specifically, this first study will examine the association between 
pre-pregnancy obesity and severe maternal morbidity and identify additional risk factors using 
Florida’s linked birth certificate and hospital discharge data from 2007-2014. The central 
hypothesis is that pre-pregnancy obesity may have a complex relationship for overall severe 
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maternal morbidity and for certain prevalent types of severe maternal morbidity. The specific 
research objective is to: 
1. Estimate the association between pre-pregnancy obesity and severe maternal morbidity in 
Florida. 
a. Estimate the specific association between pre-pregnancy obesity and the more 
prevalent individual conditions that comprise the composite measure of severe 
maternal morbidity and more prevalent individual conditions. 
b. Identify additional sociodemographic factors, medical risk factors, and individual 
and hospital health service factors associated with severe maternal morbidity. 
Second, this will be accomplished by quantifying the causes of the increased rates of severe 
maternal morbidity in Florida from 2005 to 2014, using birth certificate records linked to 
hospital discharge data. The central hypothesis is that the increased rates of severe maternal 
morbidity are driven by various factors. The specific research objective is to: 
2. Identify potential determinants of the increase in the rate of severe maternal morbidity. 
a. Identify potential determinants of the increase in the rate of blood transfusions. 
 
4 
 
 
 
 
 
 
BACKGROUND 
The Upward Trend: Severe Maternal Morbidity and Potential Risk Factors 
More than 50,000 women in the United States are affected by severe maternal morbidity 
every year,3 with rates significantly increasing from 1998 to 2011.2 Blood transfusion is the most 
common indicator of severe maternal morbidity,3,7,8 which is consistent with the general increase 
in postpartum hemorrhage and hysterectomy during delivery.9 Rates of acute renal failure, shock, 
acute respiratory distress syndrome, acute myocardial infarction, and aneurysms also increased 
by more than 75% between 1998-1999 and 2008-2009.3 In Florida, the rate of severe maternal 
morbidity also increased, with the rate increasing from 11.7 complications per 1,000 live births 
in 2004 to 19.4 complications per 1,000 live births in 2011.4 Similar to national findings, the 
rates of complications were highest for blood transfusion, disseminated intravascular 
coagulation, and heart failure during a procedure or surgery.4 
The factors influencing the increasing rates of severe maternal morbidity have not been 
fully examined, yet researchers and public health officials often cite increases in rates of 
obesity,10-12 cesarean delivery,13-17 the proportion of pregnant women with chronic conditions,13-
17 postpartum hemorrhage,9 multiple births, and advanced maternal age.18 Clinicians and 
researchers have emphasized the need to study these relationships further and identify potential 
modifiable risk factors. 
Several of the implicated risk factors have been examined in previous studies. Advanced 
maternal age is frequently mentioned as a contributor to the increase in severe maternal 
morbidity. In a nationwide study using administrative data, the rate of severe maternal morbidity 
increased in women who were older than 34 years.19 Women who were 35-39 years experienced 
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a twofold increase of severe maternal morbidity and women who were 40 years or older 
experienced a threefold increase, compared with women who were 20-34 years.19 This increase 
in risk for older women is consistent with previous reports that also found advanced maternal is 
associated with severe maternal morbidity.20-22 Osmundson et al.23 looked at the labor outcomes 
of extremely advanced maternal age women, finding that women older than 50 were five times 
more likely to experience severe maternal morbidity.23 Together, these studies suggest that the 
risk of severe maternal morbidity increases as women age. 
Literature also suggests that racial and ethnic minorities have increased risks for severe 
maternal morbidity. A large multi-state analysis found that severe maternal morbidity 
disproportionally affects racial and ethnic minority women, especially non-Hispanic black 
women.24 In a small study looking at intensive care unit admissions, non-Hispanic black women 
comprised the majority of obstetric patients admitted to the intensive care unit.16 A large study of 
women with Medicaid demonstrated that non-Hispanic black women had higher rates of 
pregnancy complications and medical comorbidities, and Hispanic women had higher rates of 
near-miss mortality.25 These findings are consistent with other studies in the United States and 
Europe, which show racial and ethnic minorities experience higher rates of severe maternal 
morbidity.16,26-29 However, the reasons for these differences are multifactorial and are likely the 
result of socioeconomic factors as well as medical comorbidities.29,30 For instance, while black 
race has been shown to predict a number of adverse maternal outcomes,20,31,32 the mechanism for 
this disparity is unknown and may involve maternal behavioral patterns, genetic predispositions, 
social circumstances, environmental exposures, and suboptimal medical care.33,34 
International studies have found associations between socioeconomic status and severe 
maternal morbidity. A recent study using data from the Australian Maternity Outcomes 
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Surveillance System found that women from the lowest socioeconomic group were twice as 
likely to experience severe complications of pregnancy compared with women from the highest 
socioeconomic group.35 Research in the United Kingdom has suggested that differences between 
women from higher and lower socioeconomic groups may be attributable to differences in the 
quality of care women receive, the way women are treated once they present for care, time of 
engagement with antenatal care, and emergency cesarean delivery.36 
Chronic medical conditions have also been suggested as contributors to the increasing 
rate of severe maternal morbidity. Cardiovascular disease during pregnancy is now a leading 
cause of global maternal morbidity and mortality.31,37-40 Cardiac surgery during pregnancy and 
the postpartum is increasing, which is consistent with the apparent increased severity of 
cardiovascular disease in pregnancy.13 Several population-level analyses have documented 
increased risk for severe maternal morbidity and mortality among women admitted with 
malignancy,41 pulmonary hypertension,42 placenta previa,43-45 sickle cell disease,46-48 
hypertensive disorders of pregnancy,32,49 chronic renal disease,42 preexisting hypertension,39,42,49 
chronic ischemic heart disease,42,46,47 congenital heart disease,13,42 systemic lupus 
erythematosus,42,46,47,50 hypercoagulable state,39,46,47 human immunodeficiency virus,51,52 valvular 
heart disease,13,42,46,47 diabetes mellitus,42,46,47 and asthma.19 
The Potential Risk Factor: Obesity and Severe Maternal Morbidity 
Focusing on obesity, it is evident that excessive weight is a major health problem in the 
United States. National data consistently demonstrate that more than two-thirds of the nation’s 
population is classified as overweight or obese.53,54 Specifically among women of reproductive 
age in the United States, the prevalence of obesity in 2011-2012 was high (31.8%), with 7.7% of 
these women being extremely obese.54 In Florida, 21.5% who had a live birth were classified as 
having pre-pregnancy obesity in 2014, with 3.7% of these women being extremely obese. 
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Despite speculation that high rates of obesity have contributed to the increased rates of 
severe maternal morbidity, the association between these two factors is not evident in the 
literature. Most previous studies that have examined severe maternal morbidity have either used 
data from obstetric intensive care unit admissions or large administrative databases. 
Unfortunately, the majority of studies examining severe maternal morbidity using obstetric 
intensive care unit admissions do not include measures of maternal weight or body mass index 
(BMI).16,25 Additionally, large studies using inpatient data with International Classification of 
Disease 9th Revision, Clinical Modification (ICD-9-CM) codes generally do not account for 
obesity.7,8 
In the small number of studies that have examined the association between obesity and 
severe maternal morbidity, the conclusions remain unclear. Five studies have used different 
methods and definitions among different populations to study the association of obesity and 
severe maternal morbidity, resulting in very different conclusions. A population-based cohort 
study of all delivery hospitals in the Netherlands found a significant crude association between 
maternal obesity and severe maternal morbidity. However, the main limitation of this study is 
that it did not adjust for confounding variables.55 Without adjusting for confounding variables, 
this study does not provide clear evidence that obesity is associated with severe maternal 
morbidity. 
In a second study using a nationwide administrative database, Mhyre et al.19 concluded 
that obesity did not predict near-miss maternal morbidity events.19 While event rates were 
increased at least twofold among obese women, the researchers suggest that coexisting medical 
diseases rather than obesity drove the relationship.19 However, the main limitation of this study is 
that it used ICD-9-CM codes to measure obesity. As the authors acknowledge, ICD-9-CM codes 
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may not be recorded reliably in administrative databases if the consequences for billing are 
minor. For this reason, common conditions, such as obesity, are typically not well coded in these 
databases. When these conditions are coded, they are likely biased. For instance, if obesity 
affects management then it is likely e coded as opposed to when it does not affect management 
or the outcome. Additionally, it is also unclear what factors were adjusted for in the multivariate 
analysis. Because of these limitations, definitive conclusions about the relationship between 
obesity and severe maternal morbidity cannot be made from this study. 
Small et al.16 conducted a small study of pregnant and postpartum patients, using clinical 
data obtained from review or maternal records and bedside observance. The researchers 
suggested that increases in the rates of obesity could explain increases in the rates of severe 
maternal morbidity. However, in their analysis, Small et al.16 found that obesity did not affect 
maternal medical co-morbidities or outcomes.16 They state in their conclusions that their study 
was limited due to the small sample size (N=86). 
In a large cohort study of 25 medical centers in the United States conducted by Grobman 
et al.,56 it appears that the researchers did not find a significant and independent association 
between obesity at delivery and severe maternal morbidity. However, it is unclear in the article 
how obesity was examined. Maternal obesity at delivery is reported in a table of patient 
characteristics; however, it is not included in the table of adjusted odds ratio results. Perhaps it 
can be assumed that obesity at delivery was not significantly and independently associated with 
severe maternal morbidity, although this is not clear from the article. 
Finally, Schummers et al.57 conducted a population-based cohort study in British 
Columbia, using abstracted data from medical records of all singleton deliveries. These 
researchers concluded that pre-pregnancy obesity was not associated with postpartum 
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hemorrhage requiring intervention or severe maternal morbidity and mortality.57 It is important 
to note that this study used a combined outcome measure of morbidity and mortality. 
In light of the limitations of the five previous studies that have examined the relationship 
between maternal obesity and severe maternal morbidity, it is hard to make conclusive decisions. 
Yet these studies do cast doubt on claims made by clinicians and public health practitioners that 
the high prevalence of obesity is contributing to the substantial increase in the rates of severe 
maternal morbidity. The lack of evidence suggests that further research needs to be done in order 
to determine the true relationship between maternal obesity and severe maternal morbidity and to 
identify modifiable risk factors and prevention opportunities. 
The Limitations: Previous Limitations of Studying Severe Maternal Morbidity 
While several studies have examined risk factors for severe maternal morbidity, these 
studies have limitations that should be mentioned. The majority of studies have either used large 
administrative databases or were conducted using a small clinical sample. Each of these types of 
studies face their own limitations. Several of the large population-based studies used nationwide 
hospital-based administrative databases. While these studies have the advantage of being able to 
examine many women, it should be recognized that these databases are primarily used for 
billing.3,7,8 Therefore, these datasets generally do not provide details regarding sociodemographic 
or clinical obstetrical risk factors for severe maternal morbidity. Many of the studies that have 
been conducted using large databases have also not accounted for maternal or hospital 
characteristics. It should also be noted that administrative datasets are subject to errors of 
omission and commission by medical coders as well as changes over time in coding practices. 
Additionally, ICD-9-CM codes have several limitations when used to identify specific 
conditions. This is true especially when attempts are made to determine the severity of a 
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condition. Unfortunately, the severity of conditions cannot be confirmed when administrative 
databases are used for analysis.  
Smaller studies based on clinical populations may not face the same challenges as studies 
that rely on administrative data, yet these studies have their own limitations. Most notable are the 
small sample sizes.16 Small sample sizes limit rigorous evaluation of the factors contributing to 
disparities in severe maternal morbidity. Studies that are based on small clinical populations do 
not have the power to determine significant associations, especially when examining rare 
conditions like severe maternal morbidity. Additionally, many of these studies rely on medical 
records that do not always record sociodemographic information. Finally, many of the large and 
small studies that have examined severe maternal morbidity have used differing definitions of 
severe maternal morbidity. Several of these definitions have not been validated or examined 
critically, which could lead to variability in results. 
In looking specifically at studies examining the association between maternal obesity and 
severe maternal morbidity, there are additional limitations for both studies using large 
administrative databases and small clinical studies. Previous studies that have utilized ICD-9-CM 
codes have not been able to examine the relationship between obesity and severe maternal 
morbidity well because obesity as a condition is neither accurate nor reliable. Yasmeen et al. 
found a weighted sensitivity of 0.17 for obesity and excessive weight gain in women with 
deliveries when looking at ICD-9-CM codes in hospital discharge data.58 Similarly, Goff et al. 
found a weighted sensitivity of 0.15 (95% Confidence Interval [CI]: 0.11–0.20] for the same 
measure.59 Smaller clinical studies are often limited by small sample sizes when examining the 
association between maternal obesity and severe maternal morbidity. 
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The Measure Itself: Differing Definitions of Severe Maternal Morbidity 
Differences in the case definition of severe maternal morbidity could potentially impact 
study results. Throughout the past two decades, there have been numerous definitions and 
methods for defining severe maternal morbidity.3,7,8,16,19,42,60,61 The original concept of severe 
maternal morbidity was introduced in 1993 by James Drife. Drife called for an expansion of the 
United Kingdom Confidential Enquiry in Maternal Death to consider “near-miss” events in an 
effort to better explain the processes leading to adverse outcomes.62 In later years, Geller et al.63 
and Gregory et al.61 incorporated this concept into their continuum of maternal delivery 
outcomes beginning with “ideal birth,” and progressing from some morbidity, to severe 
morbidity, to near-miss, and finally to maternal death. 
Historically, definitions of severe maternal morbidity typically have relied on either 
criteria available from chart review or management-based criteria, such as intensive care unit 
admission.16,64-69 But in 2004, the World Health Organization conducted a systematic review of 
studies of near-miss maternal morbidity and found that end-organ injury was a more specific and 
epidemiologically sound method to identify near-miss morbidity than management-based 
criteria.70 Furthermore, they claimed that definitions of severe maternal morbidity that are based 
on chart review have limited utility in analyzing population-level predictors of near-miss 
maternal morbidity because this outcome is rare.  
Frameworks for measuring severe maternal morbidity grew to focus more on end-organ 
injury and included measurements that could be used with administrative data to monitor severe 
maternal morbidity at the population-level. Several frameworks were constructed with antenatal 
hospitalizations as a proxy for maternal morbidity;71,72 others have used all pregnancy-related 
complications during delivery hospitalizations.73 Additionally, a scoring system was developed 
to identify the most severe morbidity using a hospital-based clinical database.56,60 This method 
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performed well, but the information that is needed to obtain the score is usually not readily 
available and is difficult to duplicate. Unless an institution has a specialized perinatal databases 
or a state collects healthcare use data beyond that based on ICD-9-CM codes, this method cannot 
be utilized to measure severe maternal morbidity. 
In an effort to standardize the measurement of severe maternal morbidity at the 
population-level, investigators in Canada grouped ICD-9-CM discharge diagnosis codes and 
Canadian classification of diagnostic, therapeutic, and surgical procedure codes to identify 
women who likely experienced severe morbidity during their delivery hospitalization.42 
Similarly, in the United States, a method was developed to identify severe maternal morbidity 
through ICD-9-CM administrative diagnosis and procedure codes that identify severe 
complications associated with an increased risk for maternal death.2,3,8,19 Researchers have also 
argued that combining ICD-9 CM codes with a requirement for prolonged length of stay 
decreases the number of identified cases, presumably by improving specificity.7 Prolonged 
length of stay greater than the 90th percentile or discharge to a second health care facility has 
been used to enhance specificity in identifying true cases of severe obstetric morbidity.7,8 While 
there will never be a clean definition of severe maternal morbidity because of the subjectivity of 
the term “severe,” these varying indicators of severe maternal morbidity generally indicate that 
something untoward occurred. 
Yet because of varying indicators, estimates of the rates of severe maternal morbidity 
also vary. A study conducted by Grobman et al.56 found that between 2008 and 2011, severe 
maternal morbidity occurred in 2.9 per 1,000 women who gave birth in the United States. This 
observed frequency was slightly lower than the rates estimated in other reports from developed 
countries. Callaghan et al.3 used data from the National Inpatient Sample to estimate that 1.5% 
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women experienced severe maternal morbidity for the years 2008–2009. This compares to 
Canadian severe maternal morbidity estimates of 0.44%42 and Dutch severe maternal morbidity 
estimates of 0.71%.55 It is likely that estimated rates were higher in the last three studies because 
the researchers utilized administrative databases that may be more sensitive in classifying severe 
maternal morbidity. 
When examining the association between specific risk factors, such as maternal obesity 
and severe maternal morbidity, it is necessary to acknowledge these varying rates. Incidences of 
severe maternal morbidity may be higher in studies that utilize administrative databases, because 
the severity of conditions is more difficult to determine. It also important to investigate the 
specific conditions that construct composite measures of severe maternal morbidity. Sensitivity 
analyses of the associations will be able to explain the relationships better and help inform 
clinicians and policy makers about specific risk factors for severe maternal morbidity. 
While there are limitations when trying to estimate rates of severe maternal morbidity, it 
is important to study these conditions and understand their risk factors. Regardless of the method 
used to quantify estimates, the rates of severe maternal morbidity are increasing. Therefore, it is 
important to identify modifiable risk factors that can be addressed. Because obesity is prevalent 
in the United States and is often cited as a contributing reason for the increases in severe 
maternal morbidity, it is important to explore this relationship further. Understanding this 
relationship can help policy makers and clinicians identify points of intervention that are 
necessary and effective. 
The Composite Measure: Severe Maternal Morbidity 
The Centers for Disease Control and Prevention developed a composite measure for 
severe maternal morbidity for the purpose of monitoring severe maternal morbidity at the state 
and hospital level.2 Many states and hospitals have already begun using this measure as a 
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surveillance tool. While composite measures can be problematic for numerous reasons, if 
hospitals and states plan to use this measure to develop quality improvement interventions, it is 
important to understand the risk factors that can be addressed and focused on for improvement. 
Additionally, specific analyses should also address the individual components of the measure. 
Most commentary about using composite measures of outcomes is related to using these 
measures in clinical trials. While the scope is different, the same arguments are valid for the 
composite measure of severe maternal morbidity. A composite outcome consists of two or more 
component outcomes. Patients who have experienced any one of the events specified by the 
components are considered to have experienced the composite outcome.74 The main advantages 
supporting the use of a composite outcome are that it increases statistical precision and efficiency 
because of higher event rates.74-79 In the case of severe maternal morbidity, this can be important 
because severe maternal morbidity rates are fortunately rare outcomes. Studying risk factors and 
characteristics associated with these rare outcomes can be studied with more efficiency. 
Additionally, modifiable risk factors can be identified, which can then be used as points of 
interventions for clinicians and public health practitioners. For individual hospitals, this can also 
be helpful in identifying trends when their individual numbers of severe maternal morbidity may 
be low. 
Unfortunately, there are several limitations when using composite outcome measures. To 
begin with, these types of measures can be misleading. This is especially true when risk factor 
effects vary across components with very different clinical importance.80 A composite measure 
implies an equivalence among components and that it unlikely to be true, particularly when the 
components are “indicators” of severity rather than measures of severity. Additionally, studies 
show that predictor effects often vary for the components of a composite measure.76,78,81 
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Therefore, it is important to clearly present data for all components and discuss composite 
findings. There are also concerns that composite outcome measures are problematic because they 
can lack logic behind the construction of the composites. Finally, critiques of composite outcome 
measures suggest that these types of measures can lead to inconsistent and unclear reporting, 
post hoc changes to the composites, and cherry picking of favorable outcomes or combinations 
of outcomes.82 It is argued that individual outcomes may be selected for inclusion in the 
composite measure to ensure statistical significance.82 Fortunately, the composite measure for 
severe maternal morbidity was developed by public health and clinical leaders. The measure is 
commonly used by state and local organizations, and it has been validated by Main et al.83 
Clinicians and public health practitioners have all been involved in the construction of the 
measure and a consensus has been given to approve the measure for its use. 
While using an accepted and validated composite measure for severe maternal morbidity 
has advantages for identifying rare outcomes at the hospital level, there are disadvantages when 
reporting composite outcomes. The relationship between risk factors and individual conditions of 
severe maternal morbidity may be hidden in the composite measure. For this reason, it seems 
necessary to analyze the individual conditions that comprise severe maternal morbidity 
separately. Together, these results can then be used to help clinicians and public health 
practitioners address modifiable risk factors that can be focused on for points of intervention. 
The Importance: Severe Maternal Morbidity, Obesity, and the Increasing Rate 
With the rates of severe maternal morbidity increasing in recent years,2 and more than 
50,000 women in the United States experiencing these serious conditions every year,3 it is 
apparent that severe maternal morbidity is a serious concern for the United States. These 
conditions often result in potential mortality, high direct medical cost, extended length of 
hospitalization, and long-term rehabilitation.3 It is imperative to study severe maternal morbidity 
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and identify modifiable risk factors in an attempt to reduce maternal morbidity and mortality in 
the United States. 
Because obesity is prevalent in the United States and is often cited as a contributing 
reason for the increases in severe maternal morbidity, it is important to explore this relationship 
further. Despite speculation that high rates of obesity have contributed to the increased rates of 
severe maternal morbidity, the association between these two factors is not evident in the 
literature. Most previous studies that have examined severe maternal morbidity have either used 
data from obstetric intensive care unit admissions or large administrative databases. 
Unfortunately, the majority of studies examining severe maternal morbidity using obstetric 
intensive care unit admissions do not include measures of maternal weight or BMI.16,25 
Additionally, large studies using inpatient data with ICD-9-CM codes generally do not account 
for obesity.7,8 It is necessary to further understanding this relationship so policy makers and 
clinicians can identify points of intervention that are necessary and effective. 
Furthermore, while the rates of severe maternal morbidity have increased in the past 
decade, the reasons for this increase are not fully understood. The increasing rates of risks factors 
associated with severe maternal morbidity have been suggested as driving the increase, but a 
formal analysis attempting to quantify the increase in the rate has not been conducted. It is 
necessary to identify potential determinants of the increase in the rate of severe maternal 
morbidity in order to focus on areas for intervention. 
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THE ROLE OF PREPREGNANCY BODY MASS INDEX IN SEVERE MATERNAL 
MORBIDITY 
 
Introduction 
During pregnancy and childbirth, some women experience maternal morbidity, defined as 
physical and psychological conditions that result from or are aggravated by pregnancy and have 
an adverse effect on a woman’s health. Severe maternal morbidity refers to the most severe 
complications of pregnancy and affects more than 50,000 women in the United States every 
year,3 with rates significantly increasing from 1998 to 2011.2 While severe maternal morbidity is 
rare, it often results in high medical costs, extended length of hospitalization, and long-term 
rehabilitation.3,84 In response, there has been a call for an organized national approach to reduce 
maternal morbidity and mortality in recent years.5 
The factors influencing the increasing rates of severe maternal morbidity have not been 
fully examined, yet researchers and public health officials often cite increases in rates of 
obesity.10-12 Obesity, once considered an epidemic in the United States, is now endemic. 
Currently, national data consistently demonstrate that more than two-thirds of the nation’s 
population is classified as overweight or obese.53,54 Specifically among women of reproductive 
age in the United States, the prevalence of obesity in 2011-2012 was high (31.8%), with 7.7% of 
these women being extremely obese.54 Rates of obesity increased in this population by 2.9% 
from 2003-2004 to 2011-2012.54 
Despite speculation that high rates of obesity have contributed to the increased rates of 
severe maternal morbidity, the association between these two factors is not evident in the 
literature. Most previous studies that have examined severe maternal morbidity have either used 
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data from obstetric intensive care unit admissions or large administrative databases. 
Unfortunately, the majority of studies using obstetric intensive care unit admissions do not 
include measures of maternal weight or body mass index (BMI).16,25 Additionally, large studies 
using inpatient data with International Classification of Disease 9th Revision, Clinical 
Modification (ICD-9-CM) codes generally do not account for obesity.7,8 In the small number of 
studies that have examined the association between obesity and severe maternal morbidity, the 
conclusions remain unclear. Five studies have used different methods and definitions among 
different populations to study the association of obesity and severe maternal morbidity, resulting 
in different conclusions.16,19,55-57 
However, regardless of the method used to quantify estimates, the rates of severe 
maternal morbidity are increasing. Therefore, it is important to identify modifiable risk factors 
that can be addressed. Because obesity is prevalent in the United States and is often cited as a 
contributing reason for the increases in severe maternal morbidity, it is important to explore this 
relationship further. Understanding this relationship can help policy makers and clinicians 
identify points of intervention that are necessary and effective. 
The objective of this study is to examine the association between prepregnancy BMI and 
severe maternal morbidity in women residing in Florida who had a live birth during 2007-2014. 
Additionally, the specific association between prepregnancy BMI and the most common 
individual conditions that comprise the composite measure of severe maternal morbidity will 
also be examined. 
Methods 
Study Design and Study Population 
We conducted a population-based retrospective cohort study using Florida’s linked birth 
certificate and maternal hospital discharge data for the years 2007-2014. More than 92% of all 
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Florida resident births in Florida hospitals are captured in the linkage, which excludes military 
hospital births, home births, and records with invalid or missing maternal social security 
numbers.85-87 We have previously reported on the improved accuracy of linked data compared to 
birth certificate or hospital discharge alone.88 Data use agreements with the Florida Department 
of Health (FDOH) and the Agency for Health Care Administration (AHCA) were completed by 
the researchers. This study was approved by the FDOH and University of South Florida 
Institutional Review Boards. 
The study population was comprised of all Florida singleton live births in routine 
delivery hospitals during 2007-2014. Births with any missing data for study variables were 
excluded from the analysis (7.6%). The final study population was comprised of 1,385,126 live 
births in Florida. 
Study Measures 
Prepregnancy BMI, the predictor variable, was calculated from prepregnancy height and 
weight recorded on the birth certificate (kg/m2). Classifications of BMI follow the 
recommendations made by The National Institutes of Health: underweight (< 18.5) normal 
weight (18.5–24.9 kg/m2); overweight (25–29.9); and obese (≥ 30). Obesity was further divided 
into: class I (30–34.9); class II (35–39.9); and class III (≥ 40).89 Severe maternal morbidity, the 
outcome variable, was measured according to International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9-CM) diagnosis and procedure codes that indicate a 
potentially life-threatening maternal condition or complication.3 This classification was based on 
a classification developed by Callaghan et al.3 and used by the Centers for Disease Control and 
Prevention.2 The California Maternal Quality Care Collaborative validated this measure and it is 
currently being used by state organizations throughout the United States.83 The current list 
captures 21 indicators of organ-system failure that represent well-defined severe events and are 
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identified by specific ICD-9-CM diagnosis and procedure codes (Table 1.). Women who have 
any ICD-9-CM code that indicates any of these potentially severe events are designated as 
experiencing severe maternal morbidity. In addition to overall severe maternal morbidity, the 
most common severe conditions were also measured as outcome variables, including: blood 
transfusion, disseminated intravascular coagulation, heart failure during a procedure or surgery, 
hysterectomy, adult respiratory distress syndrome, and ventilation. 
Additional individual and hospital factors that were examined were based on the existing 
literature and their potential clinical relevance. The factors include: sociodemographic factors, 
medical risk factors, individual health service factors, and hospital health service factors. (A 
detailed list of study variables is provided in Table 2.) The following sociodemographic factors 
were included in the final analysis: maternal age in years, race and Hispanic ethnicity, education 
level, insurance status, father’s acknowledgement, and neighborhood socioeconomic level. 
Father’s acknowledgement was classified based on presence or absence of the father’s age and 
other information on the birth certificate. It has previously been shown that no father 
acknowledgement may be a better indicator of parental support and quality of the parents’ 
relationship than marital status.90 Neighborhood socioeconomic level was identified by the 
census tract on the birth certificate. Medical factors were comprised of birth order and history of 
previous cesarean delivery, diabetes, and hypertension. Adequacy of prenatal care was included 
as an individual health service factor and measured using the Graduated Prenatal Care Utilization 
Index (GINDEX).91 
We used the U.S. Census American Community Survey (ACS) to compute the census 
tract level Index of Concentration at the Extremes (ICE)92 for race and ethnicity plus income. 
The ICE is designed to reveal the extent to which an area’s residents are concentrated into groups 
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at the extremes of deprivation and privilege: a value of -1 means that 100% of the population is 
concentrated in the most deprived group and a value of 1 means that 100% of the population is 
concentrated into the most privileged group. For the ICE for race and ethnicity plus income used 
in this analysis, the extreme groups were non-Hispanic white persons whose household income 
was greater than or equal to $100,000 (the approximate 80th income percentile) versus non-
Hispanic black persons in household whose income was less than $25,000 (the approximate 20th 
income percentile).93-95 The ICE values were then ranked as quartiles. 
The following hospital health service factors were included in the final analysis: annual 
birth volume, level of licensed neonatal care (AHCA: I-III), annual percentage of births to 
Medicaid patients (quartiles), annual percentage of births to certified nurse midwives (quartiles), 
and geographic location. We initially categorized annual birth volume in quartiles (bottom, 
second-third, top) by level of care and then combined this measure with the level of licensed 
neonatal care. We were unable to use the newer classification guidelines for neonatal care levels 
(I-IV) and the new levels of maternity care as these are not available in Florida.96,97 The 
American College of Obstetricians and Gynecologists Florida section map was used to classify 
hospital geographic location as follows: Northwestern, Northeastern, Central, Western, Eastern, 
and Southern.98 
Statistical Analysis 
Characteristics of women by BMI status were initially compared by using the chi-square 
test for categorical variables. The risk of severe maternal morbidity associated with BMI was 
then estimated by odds ratios (OR) and 95% confidence intervals (CI) derived using generalized 
estimating equations (GEE) for logistic regression. Generalized estimating equations (GEE) for 
logistic regression were used to account for the clustering of births in the same hospital and the 
same census tract. For low-prevalence outcomes such as severe maternal morbidity, odds ratios 
22 
 
(OR) and 95% confidence intervals (CI) from logistic regression are approximate estimates of 
the true risk ratio. 
We first assessed each factor individually in univariate models for severe maternal 
morbidity. Significant risk factors (P<0.05) identified in this step were selected for inclusion in a 
multivariable model, adjusting for multiple factors at a time. This was performed sequentially in 
three groups to account for the different roles of sociodemographic, medical, and health service 
factors. At each stage, the model retained factors significantly associated with severe maternal 
morbidity at the 0.05 level, in addition to year of birth to account for time-varying factors (e.g., 
annual birth volume). To determine the appropriate model, we also assessed effect modification 
by year, age, and race and ethnicity based on previous literature. In tests of interaction terms, we 
used a generalized Score test and a generalized Wald test to determine if year, age, or race and 
ethnicity are modifiers of the association between prepregnancy BMI and severe maternal 
morbidity.99 This final model was rerun separately for the most common conditions that 
comprise severe maternal morbidity as the outcome measure to assess differences by type of 
condition. Additionally, the final model was rerun for overall severe maternal morbidity without 
including blood transfusion, because blood transfusion comprised the majority of the 
morbidities. 
Diabetes and hypertension can be reasonably classified as either risk factors or maternal 
co-morbidities for severe maternal morbidity. For this reason, they were not included as 
covariates in the final model. However, separate analyses were conducted by adding diabetes and 
hypertension to the final model to assess their impact on the association between prepregnancy 
BMI and severe maternal morbidity. All analyses were performed with SAS 9.4 (SAS Institute, 
Cary, NC, USA). 
23 
 
Results 
From 2007 to 2014, the rates of women who were underweight and normal weight 
steadily decreased (underweight: 5.1% to 4.4%; normal weight: 50.4% to 46.8%), while the rates 
of women who were overweight and obese progressively increased (overweight: 24.1% to 
25.5%; obese class I: 12.0% to 13.1%, obese class II: 5.1% to 6.0%; obese class III: 3.3% to 
4.1%). Maternal individual factors and hospital factors by BMI are presented in Table 3; all 
associations were significant at a χ2 p-value of <0.0001. While there was a small increase in 
severe maternal morbidity for women outside the range of a normal weight prepregnancy BMI, 
other differences in maternal characteristics were more pronounced. Overweight and obese 
women were more likely to be older than normal weight women, be non-Hispanic black, have 
less education, and not have the father acknowledged on the birth certificate. Normal weight 
women were more likely to have private insurance and live in more privileged areas compared 
with all other BMI categories. In regards to birth history, overweight and obese women were 
more likely to have higher order deliveries with a previous cesarean delivery. Finally, diabetes 
and hypertension increased with BMI category. 
The unadjusted and adjusted odds of severe maternal morbidity are presented in Table 4. 
Overall, 20,875 women experienced severe maternal morbidity in Florida between 2007 and 
2014 (15.1 morbidities per 1,000 births). The most common morbidities were blood transfusion 
(9.9 per 1,000), disseminated intravascular coagulation (2.3 per 1,000), heart failure during a 
procedure or surgery (2.2 per 1,000), hysterectomy (0.9 per 1,000), adult respiratory distress 
syndrome (0.6 per 1,000), and ventilation (0.6 per 1,000). Unadjusted rates of severe maternal 
morbidity increased with increasing BMI; however, after risk adjustment overweight and obese 
women had slightly protective odds of severe maternal morbidity when compared with normal 
weight women. Women 35 years and older and non-Hispanic black women had increased odds 
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of severe maternal morbidity. Birth order and history of cesarean delivery also showed a strong 
association with severe maternal morbidity, with the odds of severe maternal morbidity 
increasing with birth order and history of previous cesarean delivery. Additionally, there was a 
consistent increase in odds of severe maternal morbidity with time. We did not find a significant 
interaction when we examined year, age, and race as modifiers of the relationship between 
prepregnancy BMI and severe maternal morbidity. 
When diabetes was included as a risk factor in the adjusted multivariable regression 
model, the protective effect of increasing BMI became more pronounced. This effect was even 
more striking when hypertension was also added into the model (Table 4). 
The association between prepregnancy BMI and severe maternal morbidity differs by 
types of severe maternal morbidity (Table 5). A protective dose-response relationship was seen 
for blood transfusion and disseminated intravascular coagulation, with the odds of morbidity 
decreasing with increasing BMI. The odds of heart failure, adult respiratory distress syndrome, 
and ventilation all increased with increasing BMI. 
Discussion 
This study produces important findings that offer more insight into the relationship 
between prepregnancy BMI and severe maternal morbidity. In our analysis, we found that 
increasing BMI is not associated with an increased risk of overall severe maternal morbidity after 
risk adjustment. In fact, prepregnancy overweight and obesity status has a slightly protective 
association with severe maternal morbidity. However, this association is largely driven by blood 
transfusions and disseminated intravascular coagulation, which are the two most common types 
of severe maternal morbidity and frequently coexist with each other. Aside from hysterectomy, 
the risk for the remaining morbidities seems to increase with BMI, especially for class II and III 
obesity. These contrasting findings highlight the complexities of severe maternal morbidity and 
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show the importance of analyzing severe maternal morbidity as both a composite measure and as 
individual conditions. 
The decreased adjusted risk of overall severe maternal morbidity among overweight and 
obese women runs counter to what is expected considering the crude rates of severe maternal 
morbidity by BMI status. However, our findings are consistent with previous findings and 
highlight the importance of risk adjustment. Previously, most studies have not adjusted for 
potential confounders, leading to conclusions based solely on crude associations. In our study, 
we found that women delivering after the age of 35 years, non-Hispanic black women, and 
women with a higher order of birth and a history of cesarean delivery had the greatest risk for 
severe maternal morbidity. Once these characteristics were taken into account, the risk of severe 
maternal morbidity for overweight and obese women dissipated. Three large studies found 
significant increased crude associations between obesity and severe maternal morbidity; 
however, they either did not adjust for other factors in their analysis or did not find significant 
associations after risk adjustment.19,55,56 Additionally, a very small clinical study also found a 
significant crude association but they were not able to adjust for other factors due to sample 
size.16 Finally, a fifth large study form British Columbia did not find a significant crude or 
adjusted association between severe maternal morbidity and obesity.57 Together with our study, 
these results show that once risk adjustment occurs, the increased risk of severe maternal 
morbidity among overweight and obese women dissipates. 
Blood transfusions and disseminated intravascular coagulation heavily drive the 
association between prepregnancy BMI and overall severe maternal morbidity. Therefore, it is 
especially important to understand the potential explanations for the association between obesity 
status and hemorrhage. Researchers have hypothesized that enhanced maternal 
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hypercoagulability may provide a protective effect against major blood loss in obese women. 
Obese patients tend to have a more hypercoagulable state because of higher fibrinogen, factor 
VII, factor VIII, von Willebrand factor, and plasminogen activator inhibitor levels.100 This 
hypercoagulable state increases the tendency toward blood clotting, which may reduce the risk 
for postpartum hemorrhage and explain the decreased risk of blood transfusion for overweight 
and obese women. 
As mentioned earlier, diabetes and hypertension can be reasonably classified as either 
risk factors or maternal co-morbidities for severe maternal morbidity. Furthermore, diabetes and 
hypertension are often considered obesity-related conditions.101 For this reason, there is some 
debate as to whether these conditions should be accounted for in regression modeling. We chose 
to analyze these conditions in separate analyses to assess their impact on the association between 
prepregnancy BMI and severe maternal morbidity. After accounting for them in risk adjustment, 
increasing BMI becomes strikingly protective for severe maternal morbidity. However, from a 
clinical standpoint, a pregnant woman will not present as “risk-adjusted.” A woman will present 
as obese and either have (or develop) hypertension or diabetes or she will not have (or develop) 
these conditions. Therefore, the message is that there is no increased risk of blood transfusion if 
at the time of delivery she does not have the co-morbid conditions. 
It is important to note that we did not account for mode of delivery in our analysis 
because cesarean delivery can be caused by both obesity and severe maternal morbidity. 
Cesarean delivery plays a complicated role in the relationship between maternal obesity and 
severe maternal morbidity. While the specific relationship is unclear, many individual studies 
have noted the excess risk of undergoing cesarean delivery in overweight and obese women and 
two meta-analyses have confirmed and clarified the nature and magnitude of the risk.102-107 
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Additionally, cesarean delivery is likely a more morbid procedure for obese women compared 
with normal weight women because the operation is more difficult. Furthermore, cesarean 
delivery may lead to severe maternal morbidity and vice versa. In our study, this temporal 
relationship between cesarean delivery and severe maternal morbidity is impossible to determine. 
Sick women are more likely to be delivered by cesarean for a variety of reasons, which may lead 
to confounding by indication when looking at the associations between mode of delivery and 
severe maternal morbidity. In our study, mode of delivery is affected by both the exposure (pre-
pregnancy BMI) and the outcome (severe maternal morbidity). In this type of relationship, 
cesarean delivery is a collider variable and it is inappropriate to control for mode of delivery in 
the analysis.108-111 If mode of delivery is controlled for in the analysis, it will likely bias the 
association between pre-pregnancy BMI and severe maternal morbidity. 
Our study used a composite measure for severe maternal morbidity.2 While using an 
accepted and validated composite measure for severe maternal morbidity has advantages for 
identifying rare outcomes, there are disadvantages when reporting composite outcomes. Many of 
the morbidity conditions are quite rare and the composite measure is dominated by blood 
transfusions. Therefore, the relationship between maternal obesity and specific conditions is 
hidden in the composite measure.80 However, our study has the advantage of being able to 
analyze the composite measure as a whole and analyze the most common conditions separately. 
In analyzing the separate conditions, we see that blood transfusions and disseminated 
intravascular coagulation are driving the overall association and the remaining. Aside from 
hysterectomy, the risk for the remaining most common morbidities increases with increasing 
BMI. 
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Our study has several limitations. Prepregnancy BMI was calculated from prepregnancy 
height and weight on the birth certificate, and the origins of these variables are unknown. 
However, a previous study of Florida data found that while birth certificates overestimated 
underweight and underestimated obesity prevalence, the difference was minimal and has limited 
impact on the reliability and validity for population-based surveillance and research purposes 
related to recall or reporting bias.112 Second, there is potential for misclassification when using 
administrative databases to determine cases of severe maternal morbidity. Codes in 
administrative data sets that are used primarily for billing are limited in their scope and are 
subject to errors of omission and commission.3,42 However, while identifying severe maternal 
morbidity through administrative databases may result in misclassification, the error will likely 
affect sensitivity rather than specificity as has been demonstrated in validation studies of hospital 
discharge data.58,113,114 Validation studies of co-morbidity codes for obstetric hospitalizations 
generally have reported low-to-good sensitivities and reasonable-to-high specificities and 
positive predictive values.113-115 Additionally, these approaches also may permit too many errors 
by classifying women with severe diagnoses who may not have actually had severe morbidity 
manifestations. For instance, even though it is likely that a woman who received a blood 
transfusion experienced some morbidity, it may not have been severe. Similarly, we are not able 
to determine the number of transfused units of blood. In the future, newly proposed hospital 
methods for capturing severe maternal morbidity may provide an alternative.139,140 However, 
despite the limitations of using administrative data, using this dataset provides a unique 
opportunity to study the relationship between prepregnancy BMI and severe maternal morbidity 
on a larger population basis. If we assume that no important variation in misclassification by 
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BMI category occurred, our analysis suggests that our odds ratio estimates are biased only 
slightly toward the null. 
It is important to mention that the public health message underlying the results of this 
study is not that maternal obesity is an ideal status for pregnancy. Many adverse perinatal health 
outcomes are consistently associated with maternal obesity, including many individual severe 
maternal morbidity conditions. Mothers who are obese during pregnancy are known to be at risk 
of significant antenatal, intrapartum, postpartum, and neonatal complications. Antenatal 
complications include recurrent miscarriage, congenital malformations, pregnancy-induced 
hypertension, preeclampsia, gestational diabetes mellitus, and venous thromboembolism.47,116-118 
Obese women are also more likely to have inductions of labor and require cesarean 
deliveries.119,120 Infants of overweight and obese mothers are often macrosomic and require 
prolonged hospital admissions.119,120 In addition, children who are large for gestational age at 
birth are at increased risk of developing a metabolic syndrome, thus perpetuating the cycle of 
obesity and insulin resistance in subsequent generations.121 Prepregnancy obesity is a serious 
concern that still needs to be addressed: prepregnancy obesity is not a standard that should be set 
to reduce severe maternal morbidity. 
Our study found that prepregnancy overweight and obesity status is not associated with 
an increased risk of overall severe maternal morbidity. However, this association is largely 
driven by blood transfusions and disseminated intravascular coagulation, which overweight and 
obese women are at decreased for after risk adjustment. Aside from hysterectomy, the risk for 
the remaining morbidities increases with increasing BMI. This study shows that severe maternal 
morbidity is a complex measure and not just a single condition. In future studies, it will be 
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imperative to analyze severe maternal morbidity as a composite measure and as individual 
conditions to identify modifiable risk factors to focus on for interventions.
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IDENTIFYING DETERMINANTS OF THE INCREASING RATES OF SEVERE 
MATERNAL MORBIDITY 
 
Introduction 
Severe maternal morbidity lies on the continuum of maternal morbidity that ranges from 
mild adverse events to death, and generally refers to life-threatening complications during 
delivery. Despite advances in medical care, rates of maternal mortality and morbidity have 
steadily increased over the past decade.2,122 Severe maternal morbidity occurs in roughly two 
percent of births,3 and often result in potential mortality, high direct medical cost, extended 
length of hospitalization, and long-term rehabilitation.3 In response to these concerns, there has 
been a call for an organized national approach to reduce maternal morbidity and mortality in the 
United States.5 
In order to reduce these increasing complication rates, it is first important to identify the 
factors contributing to the increased rate. Researchers and public health officials often cite 
increases in rates of obesity,10-12 cesarean delivery,13-17 the proportion of pregnant women with 
chronic conditions,13-17 postpartum hemorrhage,9 multiple births, and advanced maternal age.18 
However, these factors have not yet been fully examined and a formal analysis attempting to 
quantify the causes of the increase in the rate of severe maternal morbidity has not been 
conducted. 
Advances in the application of analytic techniques make it possible to quantify the 
components of the increase in the rate of severe maternal morbidity.123-127 This type of analysis 
will greatly add to the literature currently on severe maternal morbidity by highlighting the 
factors that are causing the increases in the rates of severe maternal morbidity. The objective of 
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this study is to identify potential determinants of the increase in the rate of severe maternal 
morbidity among women residing in Florida who had a live birth during 2005-2014. 
Methods 
Florida’s linked birth certificate and maternal hospital discharge data for the years 2005-
2014 were studied. More than 92% of all Florida resident births in Florida hospitals are captured 
in the linkage, which excludes military hospital births, home births, and records with invalid or 
missing maternal social security numbers.85-87 We have previously reported on the improved 
accuracy of linked data compared to birth certificate data or hospital discharge data alone.88 Data 
use agreements with the Florida Department of Health (FDOH) and the Agency for Health Care 
Administration (AHCA) were completed by the researchers. This study was approved by the 
FDOH and the University of South Florida Institutional Review Boards.  
The study population is comprised of all Florida live births in routine delivery hospitals 
in 2005 N=184, 811) and 2014 (N=181,187). Births with missing data for study variables were 
excluded (8.2%). Trends were examined using 1,865,296 live births in Florida from 2005 
through 2014. 
Study Measures 
We examined severe maternal morbidity rates and related risk factors in live births to 
Florida women between 2005 and 2014. Severe maternal morbidity was measured according to 
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) 
diagnosis and procedure codes that indicate a potentially life-threatening maternal condition or 
complication.3 This classification was based on a classification developed by Callaghan et al.3 
and is used by the Centers for Disease Control and Prevention.2 The California Maternal Quality 
Care Collaborative validated this measure and it is currently being used by state organizations 
throughout the United States.83 The current recommended list captures 21 indicators of organ-
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system failure that represent well-defined severe events and are identified by specific ICD-9-CM 
diagnosis and procedure codes (Table 1). Women who have any ICD-9-CM code that indicates 
any of these potentially severe events are designated as having severe maternal morbidity. In 
addition to overall severe maternal morbidity, the rates of severe maternal morbidity not 
including blood transfusions and the rates of blood transfusions were analyzed separately 
because the composite measure of severe maternal morbidity is dominated by blood transfusions 
(62%). 
Additional individual and hospital factors were examined based on the existing literature 
and their potential clinical relevance. The factors include: sociodemographic factors, medical 
risk factors, individual health service factors, and hospital health service factors. (A detailed list 
of study variables is provided in Table 6.) The following sociodemographic factors were 
included in the final analysis: maternal age in years, race and Hispanic ethnicity, education level, 
insurance status, and father’s acknowledgement. Father’s acknowledgement was classified based 
on presence or absence of the father’s age and other information on the birth certificate. It has 
previously been shown that father acknowledgement may be a better indicator of parental 
support and quality of the parents’ relationship than marital status.90 Medical factors were 
comprised of prepregnancy body mass index (BMI), birth order and history of cesarean delivery, 
and plurality. Adequacy of prenatal care was included as an individual health service factor and 
measured using the Graduated Prenatal Care Utilization Index (GINDEX).91 
The following hospital health service factors were included in the final analysis: annual 
birth volume, level of licensed neonatal care (AHCA: I-III), annual percentage of births to 
Medicaid patients (quartiles), annual percentage of births attended by certified nurse midwives 
(quartiles), and geographic location. We initially categorized annual birth volume in quartiles 
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(bottom, second-third, top) and then combined this measure with the level of licensed neonatal 
care. We are unable to use the newer classification guidelines for neonatal care levels (I-IV) and 
the new levels of maternity care as these are not available in Florida.96,97 The American College 
of Obstetricians and Gynecologists Florida section map was used to classify hospital geographic 
location as follows: Northwestern, Northeastern, Central, Western, Eastern, and Southern.98 
Statistical Analysis 
We initially conducted a Kitagawa analysis to evaluate the components of the increased 
rate of severe maternal morbidity between 2005 and 2014. The Kitagawa method provides a 
decomposition of the absolute difference in the overall severe maternal morbidity rate into the 
differences in the proportion of women with specific factors and the differences in the severe 
maternal morbidity rates among women with those specific sociodemographic, medical, and 
individual and hospital health service factors. This method has been described in detail 
elsewhere.128-130 
Additionally, we performed a multivariable regression analysis to estimate the 
contribution of the multiple factors to differences in the rate of severe maternal morbidity in 
2005 and 2014. We used Oaxaca-Blinder decomposition to assess the contribution of prevalence 
differences in each factor to the increase of severe maternal morbidity between the two time 
periods.123-127,131 This method requires estimating linear models because these types of model 
have the desirable property of the mean of the dependent variable equaling the sum of the mean 
values of the independent variables multiplied by their respective coefficients.127 We used 
ordinary least squares regression to satisfy this requirement. For binary responses, this type of 
regression is known as a linear probability model and provides unbiased estimators of 
coefficients but requires robust standard errors to account for heteroskedasticity.132 The overall 
crude difference between the rate of severe maternal morbidity in 2005 and 2014 (Y2014 – Y2005) 
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is equal to the unexplained disparity from the adjusted model (ß2014) plus the sum of the adjusted 
effects (ß coefficients) multiplied by the prevalence difference for each factor (∑ 𝛽𝑖(𝑋𝑖2014 −
𝑘
𝑖
𝑋𝑖2005)): 
𝑌2014 − 𝑌2005 = 𝛽2014 +∑ 𝛽𝑖(𝑋𝑖2014 − 𝑋𝑖2005).
𝑘
𝑖
 
The percentage of the difference in the rate between 2005 and 2014 explained by each factor can 
be calculated as 
𝛽𝑖(𝑋𝑖2014−𝑋𝑖2005)
𝑌2014−𝑌2005
× 100. 
Diabetes and hypertension can be reasonably classified as either risk factors or maternal 
co-morbidities for severe maternal morbidity. For this reason, they were not included as 
covariates in the initial multivariable regression analysis; however, they were added as covariates 
to the final model in a separate analysis to assess their contribution to differences in the rate of 
severe maternal morbidity in 2005 and 2014. Similarly, mode of delivery was also not included 
as a covariate in the initial multivariable regression analysis because the temporal relationship 
between cesarean delivery and severe maternal morbidity is impossible to determine in the 
dataset. However, it was also added as a covariate to the final model to assess its contribution to 
differences in the rate of severe maternal morbidity between the two time periods. To further 
explore potential reasons for the increase in blood transfusions, we assessed rates of obstetric 
hemorrhage related complications over time using ICD-9-CM diagnosis codes (Table 7).133,134 
All analyses were performed with SAS 9.4 (SAS Institute, Cary, NC, USA). 
Results 
The rate of severe maternal morbidity in 2014 was 19.3 per 1,000 live births, which was 
1.65 times higher than the rate in 2005 (95% Confidence Interval [CI]: 1.56-1.74) (Table 8). 
Given that the average number of live births in Florida is about 200,000 per year, the excess in 
severe maternal morbidity between 2004 and 2015 translates to about 1,520 morbidities annually 
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that would have been prevented if women delivering in 2014 had the same risk of severe 
maternal morbidity as women delivering in 2005. Among the most prevalent individual 
conditions of severe maternal morbidity, the rate of severe maternal morbidity in 2014 
significantly exceeded the rate in 2005 for blood transfusions, disseminated intravascular 
coagulation, and ventilation. The rate of heart failure during a procedure or surgery in 2014 was 
significantly less than the rate in 2005. In separating blood transfusions from the rest of the 
conditions, it is apparent that the increase in severe maternal morbidity is driven primarily by 
blood transfusions (Figure 1). While the overall rate difference between 2005 and 2014 was 7.6 
morbidities per 1,000 live births (95% CI: 6.8-8.4) for overall severe maternal morbidity, it was 
8.6 (95% CI: 7.8-9.0) for blood transfusions and only 0.1 (95% CI: -0.4-0.7) for severe maternal 
morbidity not including blood transfusions. 
Nearly all of the excess severe maternal morbidity and blood transfusions in 2014 can be 
explained by differences in the rate of severe maternal morbidity and blood transfusion between 
the two time periods (Table 9 and 10). Conversely, almost none of the excess can be explained 
by differences in the distributions of sociodemographic factors, medical factors, and individual 
and hospital health service factors in the two time periods. In fact, the proportion of women with 
a higher order delivery and history of cesarean delivery was the greatest contributor toward both 
the excess rate of severe maternal morbidity and blood transfusion, and only explained 7.2% of 
the increase in overall severe maternal morbidity and 3.8% of the increase in blood transfusions. 
The contribution of factors for severe maternal morbidity not including blood transfusions is not 
shown because there was not a significant difference in the rate between the two time periods. 
Women delivering in 2014 were more likely than women delivering in 2005 to be 35 
years or older, non-Hispanic black or Hispanic, have Medicaid, not have a father acknowledged 
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on the birth certificate, be overweight or obese at prepregnancy, and have a high birth order and 
previous cesarean delivery (Table 11). In adjusted models, all covariates were significantly 
related to severe maternal morbidity and blood transfusions, with the exception of prepregnancy 
overweight and obesity status. Differences in education favored women delivering in 2014, as 
women in the later time period were more likely to have some college or greater education. In 
total, these covariates explained 9.1% of the overall severe maternal morbidity increase in 2014 
compared with 2005, and only explained 2.5% of the increase in blood transfusions during this 
time period. Again, results for severe maternal morbidity not including blood transfusions are not 
shown because there was not a significant difference in the rate between the two time periods. 
In the sensitivity analyses (Table 12 and 13), diabetes and hypertension explained very 
little of the increase in severe maternal morbidity (1.9% and 2.3%, respectively) and even less of 
the increase in blood transfusions (0.7% and 1.3%, respectively). The proportion of women with 
a cesarean delivery explained 9.3% of the increase in the rate of severe maternal morbidity and 
4.7% of the increase in the rate of blood transfusions. When diabetes and hypertension were 
added to the adjusted model (Table 14), all of the covariates explained 11.4% of the overall 
severe maternal morbidity increase in 2014 compared with 2005, and explained 6.2% of the 
increase in blood transfusions during this time period. When cesarean delivery was added to the 
adjusted model (Table 15), all of the covariates explained 5.4% of the overall increase in severe 
maternal morbidity, and only explained 0.64% of the increase in blood transfusions. Despite the 
increasing rates of blood transfusions from 2005 to 2014, the rates of obstetric hemorrhage-
related complications did not increase during this same period (Figure 2). 
Discussion 
In our study, we found an increase in the rate of overall severe maternal morbidity 
between 2005 and 2014, which is consistent with national trends.2,122 Women delivering in 2014 
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were 1.65 times more likely to experience severe maternal morbidity compared with women 
delivering in 2005. However, this increase in severe maternal morbidity was driven almost 
entirely by a dramatic increase in blood transfusions. While there were substantial and significant 
differences in the populations of women delivering between 2005 and 2014, these distributional 
differences did not explain, or in other words contribute to, the striking increase of blood 
transfusions during this time period. Consistent with our findings, previous studies have 
consistently shown that blood transfusion is generally the most common indicator of severe 
maternal morbidity and has been increasing in recent years.3,7,8 However, earlier studies have 
also shown a general increase in postpartum hemorrhage in the United States.3,9 We did not see 
this increase in related complications in Florida from 2005 to 2014. In our analysis, blood 
transfusion rose while the reported rates of obstetric hemorrhage remained relatively stable. 
These differences may be due to the different time periods that were analyzed or regional 
differences in morbidity and medical practices in the United States. 
Previous studies have suggested the increase of severe maternal morbidity to increases in 
rates of obesity,10-12 multiple births, and advanced maternal age.18 Although our study 
documented significant and substantial increases in these risk factors, we did not find any of 
these factors to be substantial contributors to the increase in severe maternal morbidity in 
Florida. In a previous study that examined the rates of severe maternal morbidity, Kuklina et al.8 
looked at various factors to explain the increase of severe maternal morbidity in a nationwide 
cross-sectional study using data from 1998 to 2005. The researchers concluded that maternal age 
did not appear to contribute substantively to the increases in risk. However, increasing rates of 
cesarean delivery from 1998-2005 seemed to explain the observed change over time for renal 
failure, respiratory distress syndrome, and ventilation.8 Changes in cesarean delivery rate, 
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although only partially, also contributed to the increases in shock, pulmonary embolism, and 
blood transfusions.8 In our updated analysis, we looked at mode of delivery to explain the 
increase in severe maternal morbidity in a sensitivity analysis. We chose not to include mode of 
delivery in the original model because cesarean delivery may lead to severe maternal morbidity 
and vice versa. In our study and the study conducted by Kuklina et al.,8 this temporal 
relationship between cesarean delivery and severe maternal morbidity is impossible to determine. 
Sick women are more likely to be delivered by cesarean for a variety of reasons, which may lead 
to confounding by indication when looking at the associations between mode of delivery and 
severe maternal morbidity. In our analysis, cesarean delivery explained approximately 10% of 
the increase in the rate of severe maternal morbidity and approximately 5% of the increase in the 
rate of blood transfusions in both the unadjusted and adjusted analyses. Despite the limitations in 
using this measuring in a cross-sectional analysis, it is likely that cesarean delivery is an 
important driver in the increase of severe maternal morbidity and blood transfusions. 
Another potential explanation for the increase in blood transfusions is that recent state 
and national initiatives to reduce complications related to obstetric hemorrhage may have led to 
an increase in blood transfusions.135,136 With hemorrhage being the leading cause of pregnancy-
related maternal death in Florida,137 an emphasis has been placed on the implementation of 
hemorrhage protocols in all Florida delivery hospitals.136,138 These protocols include a massive 
transfusion protocol, in addition to simulation drills and hemorrhage carts. Yet Florida’s 
perinatal collaborative did not start its hemorrhage initiative until the fall of 2013 in hospitals 
that deliver nearly half of the state’s births. In 2014, the first full year of implementation, the 
annual increase was equivalent to the annual increase over the entire study time period. Still, in 
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an effort to prevent maternal death and severe maternal morbidity, hospitals may be increasing 
the frequency of blood transfusions. 
Still it is also possible that the increase in blood transfusions can be attributed to a change 
in reporting practices. Hospitals may have increased the reporting of blood transfusions in later 
years. However, given the dramatic increase, it is unlikely that an increase in reporting could 
explain the entire increase of blood transfusions. 
It is important to note that our study used a composite measure for severe maternal 
morbidity.2 While using an accepted and validated composite measure for severe maternal 
morbidity has advantages for identifying rare outcomes, there are disadvantages when reporting 
composite outcomes. The relationship between risk factors and specific conditions may be 
hidden in the composite measure.80 Many of the morbidity conditions are quite rare and the 
composite measure is dominated by blood transfusions. However, our study has the advantage of 
being able to analyze the composite measure as a whole and analyze severe maternal morbidity 
without including blood transfusions. 
The advantage of capturing the vast majority of births in Florida in the linked birth 
certificate and hospital discharge data was mitigated by some limitations in the measurement of 
some factors. The potential for misclassification exists when using administrative databases to 
determine cases of severe maternal morbidity. Codes in administrative data sets that are used 
primarily for billing are limited in their scope and are subject to errors of omission and 
commission.3,42 However, while identifying severe maternal morbidity through administrative 
databases may result in misclassification, the error will likely impact sensitivity rather than 
specificity as has been demonstrated in validation studies of hospital discharge data.58,113,114 
Validation studies of comorbidity codes for obstetric hospitalizations generally have reported 
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low-to-good sensitivities and reasonable-to-high specificities and positive predictive values.113-
115 Additionally, the definition of severe morbidity in studies using administrative databases is 
generally based on the occurrence of predefined events, such as eclampsia or blood 
transfusion.3,42,55 Yet the possibility remains that determining morbidity through ICD-9-CM 
codes in administrative databases could miss some women who had severe morbidity because of 
other diagnoses or causes. Yet these approaches also may permit too many errors by classifying 
women with severe diagnoses who may not have actually had severe morbidity manifestations. 
For instance, even though it is likely that a woman who received a blood transfusion experienced 
some morbidity, it may not have been severe. Similarly, we are not able to determine the number 
of transfused units of blood. In the future, newly proposed hospital methods for capturing severe 
maternal morbidity may provide an alternative.139,140 Finally, our study was limited to the state of 
Florida and this study may not be generalizable to other populations. However, despite the 
limitations of using administrative data, using this dataset provides a unique, and currently the 
only, opportunity to study the increase in the rates of severe maternal morbidity and blood 
transfusions on a population-basis over time. 
Our study findings regarding the increase in the rate of severe maternal morbidity 
indicate that the increase is comprised almost entirely by an increase in the rate of blood 
transfusions. However, this increase cannot be explained by changes in the distribution of 
sociodemographic, medical history, or individual and hospital health service factors. The 
emphasis on state and national initiatives to prevent complications from obstetric hemorrhage is 
a possible explanation for the increase in transfusions; however, the rate of obstetric hemorrhage 
has not increased. Further research will need to be conducted to explain the increase in the rate of 
severe maternal morbidity and blood transfusions. 
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CONCLUSIONS AND IMPLICATIONS 
 
The rates of severe maternal morbidity are increasing in Florida; however, these two 
studies indicate that this increase is driven almost entirely by blood transfusions, which is 
generally a proxy measure for severe hemorrhage. While the rate for the majority of conditions 
has remained stagnant in the past decade, blood transfusions have increased substantially and 
significantly. Yet the reason for this increase cannot be readily explained by the traditional 
factors using birth certificate and hospital discharge data. As public health practitioners and 
clinicians work to develop initiatives to decrease the rates of severe maternal morbidity, they 
need to recognize that these high and increasing rates are driven primarily by blood transfusions. 
Furthermore, blood transfusions, when measured as any type of transfusion, have different risk 
factors associated with it than the other conditions of severe maternal morbidity. 
Major Study Findings 
There are several possible explanations for this increase in blood transfusions. First, 
recent state and national initiatives to reduce complications related to obstetric hemorrhage may 
have led to an increase in blood transfusions.135,136 With hemorrhage being the leading cause of 
pregnancy-related maternal death in Florida,137 an emphasis has been placed on early recognition 
and the implementation of hemorrhage protocols in all Florida delivery hospitals.136,138 These 
protocols include a massive transfusion protocol, in addition to having simulation drills and 
hemorrhage carts. Hospitals have also been encouraged to quantify blood loss in an effort to 
recognize hemorrhage requiring transfusion at an earlier stage. However, Florida’s perinatal 
collaborative did not start its hemorrhage initiative in 32 hospitals until the fall of 2013. These 32 
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hospitals deliver nearly half of the state’s births. In 2014, the first full year of implementation, 
Florida’s annual increase in transfusion was equivalent to the annual increase over the entire ten-
year study time period. Therefore, while these initiatives to reduce complications related to 
obstetric hemorrhage may have contributed to an increase in blood transfusions in later study 
years, they likely cannot explain the entire increase. 
Blood transfusions may be a marker for maternal morbidity and not severe maternal 
morbidity. The number of units of blood cannot be determined from the current administrative 
databases, meaning that the severity of blood loss cannot be determined. Currently, hospital 
discharge coding captures any blood transfusion. In the future, newly proposed hospital methods 
for capturing severe maternal morbidity may provide an alternative.139,140 This includes hospitals 
systematically reviewing and reporting all maternal discharges where the mother receives four or 
more units of blood products or is admitted to an intensive care unit. Additionally, the increase in 
“any” blood transfusions may serve as a proxy for other lesser conditions. It is possible that 
unidentified underlying conditions have been increasing, which led to an increase in blood 
transfusions. Alternatively, the increase in blood transfusions may be attributed to a change in 
hospital reporting practices potentially related to reimbursement or other reasons. Further 
research is needed in order to understand the reasons for the large increase. 
In recognizing the impact blood transfusions have on measuring overall severe maternal 
morbidity, the complexities of using a composite measure to measure severe maternal morbidity 
must be recognized. In this situation, blood transfusion dominates the composite measure and 
drives all trends and association. For this reason, the national recommendation is to both monitor 
severe maternal morbidity with or without transfusion. Blood transfusion is a different condition 
than the remaining 20 conditions that comprise severe maternal morbidity as many of the 
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conditions are. For example, the protective effect seen in the association between blood 
transfusions and prepregnancy overweight and obesity is also seen in the association with 
disseminated intravascular association. The remaining conditions either see an increased risk of 
severe maternal morbidity with increasing body mass index (BMI) or no association at all. 
Understanding the differences between these conditions and the different risk factors associated 
with them will be important in using severe maternal morbidity as an outcome measure for 
quality improvement initiatives as the impact on the various conditions may vary. 
Strengths and Limitations 
These two studies examining severe maternal morbidity rates have several strengths. 
First, the linked birth certificate and hospital discharge dataset used for these analyses captures a 
large study population representing nearly all births in Florida. As result of this large study 
population, the composite measure could be separated in both studies to explore associations 
with individual conditions. This study population also made it possible to analyze a plethora of 
sociodemographic factors, medical risk factors, and individual and hospital health service 
factors. The studies explaining the relationship between prepregnancy body mass index and 
severe maternal morbidity will contribute to the literature of severe maternal morbidity by 
clearly showing the protective association between prepregnancy overweight and obesity status 
and blood transfusions and disseminated intravascular coagulation. Additionally, despite not 
being able to fully explain the increase of severe maternal morbidity, a thorough investigation 
was completed and shows the increase in severe maternal morbidity is driven almost completely 
by blood transfusions. This differs from other studies reporting increases in maternal age, 
obesity, and chronic diseases. 
The advantage of capturing the vast majority of births in Florida in the linked birth 
certificate and hospital discharge data was mitigated by some limitations in the measurement of 
45 
 
some factors. The potential for misclassification exists when using administrative databases to 
determine cases of severe maternal morbidity. Codes in hospital discharge data sets that are used 
primarily for billing are limited in their scope and are subject to errors of omission and 
commission.3,42 However, while identifying severe maternal morbidity through administrative 
databases may result in misclassification, the error will likely impact sensitivity rather than 
specificity as has been demonstrated in validation studies of hospital discharge data.58,113,114 
Validation studies of comorbidity codes for obstetric hospitalizations generally have reported 
low-to-good sensitivities and reasonable-to-high specificities and positive predictive values.113-
115 Additionally, the definition of severe morbidity in studies using discharge data is generally 
based on the occurrence of predefined events, such as eclampsia or blood transfusion.3,42,55 Yet 
the possibility remains that determining morbidity through ICD-9-CM codes in administrative 
databases could miss some women who had severe morbidity because of other diagnoses or 
causes. These approaches also may permit errors by classifying women with severe diagnoses 
who may not have actually had severe morbidity manifestations. For instance, even though it is 
likely that a woman who received a blood transfusion experienced some morbidity, it may not 
have been severe. Similarly, the number of transfused units of blood could not be determined. In 
the future, newly proposed hospital methods for capturing severe maternal morbidity may 
provide an alternative.139,140 
Additionally, prepregnancy BMI was calculated from prepregnancy height and weight on 
the birth certificate, and the origins of these variables are unknown. However, a previous study 
of Florida data found that while birth certificates overestimated underweight and underestimated 
obesity prevalence, the difference was minimal and has limited impact on the reliability and 
validity for population-based surveillance and research purposes related to recall or reporting 
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bias.112 Finally, the analyses were limited to the state of Florida and may not be generalizable to 
other populations. However, despite the limitations of using administrative data, using this 
dataset provides a unique, and currently the only, opportunity to study the increase in severe 
maternal morbidity and blood transfusion rates on a population-basis over time and the 
opportunity to study the relationship between prepregnancy BMI and severe maternal morbidity 
on a larger population basis. 139,140 
Implications for Surveillance 
As seen in both studies, some issues should be considered when using the composite 
measure of severe maternal morbidity. The Centers for Disease Control and Prevention 
developed the composite measure for severe maternal morbidity for the purpose of monitoring 
severe maternal morbidity rates at a national, state, and hospital level.2 Many states and hospitals 
use this measure as a surveillance and quality improvement measure. However, blood transfusion 
is a very different condition than the remaining twenty severe maternal morbidity conditions. 
Therefore, as hospital and states monitor severe maternal morbidity rates, they should monitor 
both severe maternal morbidity rates with and without blood transfusions. Additionally, newly 
proposed hospital methods for capturing severe maternal morbidity should be considered as an 
alternative because the number of transfused units of blood cannot be determined in the current 
administrative databases.139,140 
Implications for Quality Improvement Initiatives 
There are also implications for obstetric hemorrhage and other quality improvement 
initiatives. While the impact of these initiatives on the increased rate of blood transfusions in 
Florida is unclear, continuing to monitor their impact in the future will be critical. While adverse 
reactions associated with blood transfusions are rare, complications can occur. Allergic and 
febrile reactions are the most common adverse reactions from blood transfusions. Infections 
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caused by bacterial and viral contamination of blood products and immune reactions due to 
problems in blood type matching between donor and recipient are rare but can occur.141 
Hospitals may need to review their protocol to ensure that blood product resources are used 
wisely. 
Implications for Policy 
Focusing specifically on obesity and severe maternal morbidity, the public health 
message should not be that maternal obesity is an ideal status for pregnancy. While the risk of 
severe maternal morbidity may be less, many adverse perinatal health outcomes are consistently 
associated with maternal obesity, including the majority of the individual severe maternal 
morbidity conditions. Mothers who are obese during pregnancy are at a higher risk of pregnancy-
related death142 and are known to be at risk of significant antenatal, intrapartum, postpartum, and 
neonatal complications. Antenatal complications include recurrent miscarriage, congenital 
malformations, pregnancy-induced hypertension, preeclampsia, gestational diabetes mellitus, and 
venous thromboembolism.47,116-118 Obese women are also more likely to have inductions of labor 
and require cesarean deliveries.119,120 Infants of overweight and obese mothers are often 
macrosomic and require prolonged hospital admissions.119,120 In addition, children who are large 
for gestational age at birth are at increased risk of developing a metabolic syndrome, thus 
perpetuating the cycle of obesity and insulin resistance in subsequent generations.121 
Prepregnancy obesity is a serious concern that still needs to be addressed: prepregnancy obesity 
is not a standard that should be set to reduce severe maternal morbidity or blood transfusions. 
Implications for Research 
In future research, methods and measures to explain the dramatic increase of blood 
transfusions need to be developed. While the increase in obstetric hemorrhage rates in Florida 
have not been reported previously, the increasing rate of blood transfusions indicates a 
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potentially dramatic increase in hemorrhage. Therefore, research should be conducted to 
determine if blood transfusions are increasing because of hemorrhage, quality improvement 
initiatives, reporting practices, or other factors. As hospitals adopt the newly proposed methods 
for capturing severe maternal morbidity,139,140 investigations should be conducted to determine if 
the same increases in blood transfusions are evident. Developing additional measures for 
moderate maternal morbidity may also be necessary in fully explaining the increasing rates of 
maternal morbidity and making efforts to reduce these rates. 
Final Conclusions 
Consistent with national trends,2,122 the rates of severe maternal morbidity have been 
increasing in Florida. This increase is driven almost entirely by blood transfusions and cannot be 
explained by traditional factors that are readily available in current datasets. In addition to the 
differences between the trends of blood transfusions and the 20 severe maternal morbidity 
conditions, there are also differences in risk factors associated with these different conditions. 
Prepregnancy overweight and obesity is associated with a protective effect with blood 
transfusions and disseminated intravascular coagulation that is not seen in the other conditions. 
Therefore, initiatives to decrease the rates of severe maternal morbidity will need to take these 
differences into account. 
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TABLES 
 
Table 1. Severe Maternal Morbidity Indicators and Corresponding ICD-9-CM Codes2,3 
 
Severe Maternal Morbidity Indicator ICD-9-CM Codes 
ICD-9-CM 
Diagnosis 
Code 
ICD-9-CM 
Procedure 
Code 
1. Acute myocardial infarction 410.xx x  
2. Acute renal failure 584.x, 669.3x x  
3. Adult respiratory distress syndrome 518.5, 518.81, 518.82, 518.84,799.1 x  
4. Amniotic fluid embolism 673.1x x  
5. Aneurysm 441.xx x  
6. Cardiac arrest/ventricular fibrillation 427.41, 427.42, 427.5 x  
7. Disseminated intravascular coagulation 286.6, 286.9, 666.3x x  
8. Eclampsia 642.6x x  
9. Heart failure during procedure or surgery 669.4x, 997.1 x  
10. Puerperal cerebrovascular disorders 430, 431, 432.x, 433.xx, 434.xx, 436, 437.x, 671.5x, 674.0x, 997.2, 999.2 x  
11. Pulmonary edema 428.1, 518.4 x  
12. Severe anesthesia complications 668.0x, 668.1x, 668.2x x  
13. Sepsis 038.xx, 995.91, 995.92 x  
14. Shock 669.1x, 785.5x, 995.0, 995.4, 998.0 x  
15. Sickle cell anemia with crisis 282.62, 282.64, 282.69 x  
16. Thrombotic embolism 415.1x, 673.0x, 673.2x, 673.3x, 673.8x x  
17. Blood transfusion 99.0x  x 
18. Conversion of cardiac rhythm 99.6x  x 
19. Hysterectomy 68.3x-68.9  x 
20. Temporary tracheostomy 31.1  x 
21. Ventilation 93.90, 96.01-96.05, 96.7x  x 
Note: ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification 
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Table 2. Factors Examined in Multivariable Regression Modeling 
Characteristics Data Source 
Prepregnancy Body Mass Index (kg/m2) 
     Underweight (18.5 and less) 
     Normal weight (18.5–24.9) 
     Overweight (25–29.9) 
     Obese class I (30–34.9) 
     Obese class II (35-39.9) 
     Obese class III (40 and greater) 
Birth Certificate 
Sociodemographic Factors 
Maternal Age 
     <20 years 
     20-34 years 
     ≥35 years 
Birth Certificate 
Maternal Race and Ethnicity 
     Non-Hispanic White 
     Non-Hispanic Black 
     Hispanic 
     Other 
Birth Certificate 
Maternal Education 
     Less Than High School 
     High School Diploma/GED 
     Some College or greater 
Birth Certificate 
Insurance Status 
     Medicaid 
     Private 
     Self-pay 
     Other 
Hospital Discharge 
Father Acknowledged on Birth Record 
     Yes 
     No 
Birth Certificate 
ICE for Race and Ethnicity Plus Income Quartile 
     Bottom quartile 
     Second quartile 
     Third quartile 
     Fourth quartile 
U.S. Census Bureau (ACS) 
Medical Risk Factors 
Birth Order and History of Cesarean Delivery 
     First delivery 
     Second or third, without previous cesarean delivery 
     Second or third, with previous cesarean delivery 
     Fourth or later, without previous cesarean delivery 
     Fourth or later, with previous cesarean delivery 
Birth Certificate 
Maternal Diabetes Hospital Discharge, Birth Certificate 
Maternal Hypertension Hospital Discharge, Birth Certificate 
Individual Health Service Factors 
Adequacy of Prenatal Care (GINDEX) 
     Intensive/Adequate 
     Intermediate 
     Inadequate 
     No Care 
     Unknown 
 
 
Birth Certificate 
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Table 2, continued. Factors Examined in Multivariable Regression Modeling 
Hospital Health Service Factors 
Level of NICU and Annual Hospital Birth Volume Quartile 
     Level I; Bottom quartile 
     Level I; Second-third quartile 
     Level I; Top quartile 
     Level II; Bottom quartile 
     Level II; Second-third quartile 
     Level II; Top quartile 
     Level III; Second-third quartile 
     Level III; Top quartile 
Florida Agency for Health Care Administration 
Birth Certificate 
Hospital Percentage of Medicaid Births Quartile 
     Bottom quartile 
     Second-third quartile 
     Fourth quartile 
Hospital Discharge 
Hospital Percentage of Certified Nurse Midwife Births 
     Bottom quartile 
     Second-third quartile 
     Fourth quartile 
Birth Certificate 
Florida Geographic Location 
     Northwestern 
     Northeastern 
     Central 
     Western 
     Eastern 
     Southern 
Birth Certificate 
Year of Delivery 
Year of Delivery 
     2007 
     2008 
     2009 
     2010 
     2011 
     2012 
     2013 
     2014 
Hospital Discharge, Birth Certificate 
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Table 3. Severe Maternal Morbidity, Individual, and Hospital Factors by Body Mass Index in Florida, 2007-2014 
Factors 
Prepregnancy Body Mass Index (BMI) (kg/m2) 
Underweight 
≤18.5 
Normal 
Weight 
18.5-24.9 
Overweight 
25-29.9 
Obese 
Class I 
30-34.9 
Obese 
Class II 
35-39.9 
Obese 
Class III 
≥40 
 N = 66,662 N = 672,775 N = 345,196 N = 171,939 N = 77,433 N = 51,121 
 % % % % % % 
Severe Maternal Morbidity 
   Yes 1.6% 1.4% 1.5% 1.6% 1.7% 1.9% 
   No 98.4% 98.6% 98.5% 98.4% 98.3% 98.1% 
Sociodemographic Factors 
   Age (years) 
      Younger than 20 16.3% 9.9% 7.3% 6.2% 5.2% 3.8% 
      20-34 75.5% 75.5% 76.5% 77.6% 79.8% 81.4% 
      35 and older 8.2% 14.5% 16.2% 16.2% 15.0% 14.8% 
   Race and Ethnicity 
      Non-Hispanic white 51.8% 50.0% 42.3% 41.1% 42.9% 41.0% 
      Non-Hispanic black 16.9% 15.2% 20.1% 24.8% 28.7% 36.1% 
      Hispanic 23.3% 29.3% 33.9% 31.6% 26.6% 21.6% 
      Other 8.0% 5.5% 3.6% 2.5% 1.7% 1.4% 
   Education 
      Less than high school 21.3% 14.5% 15.7% 16.4% 15.5% 15.0% 
      High school graduate or GED 34.7% 29.3% 32.4% 34.9% 36.4% 38.4% 
      Some college or greater 44.0% 56.2% 51.9% 48.7% 48.1% 46.6% 
   Insurance Status 
      Medicaid 59.8% 47.8% 52.6% 56.7% 58.6% 61.9% 
      Private 35.3% 47.5% 43.2% 39.8% 38.9% 36.4% 
      Self-pay 4.0% 3.7% 3.1% 2.5% 1.7% 1.1% 
      Other 0.9% 1.0% 1.1% 0.9% 0.7% 0.6% 
NOTE: All values are significant at a χ2 p-value of <0.0001 
* Based on whether or not the father’s age is reported on the birth certificate 
† Index of Concentration at the Extremes 
§ Graduated Prenatal Care Utilization Index 
¶ Neonatal Intensive Care Unit 
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Table 3, continued. Severe Maternal Morbidity, Individual, and Hospital Factors by Body Mass Index in Florida, 2007-2014 
Factors 
Prepregnancy Body Mass Index (BMI) (kg/m2) 
Underweight 
≤18.5 
Normal 
Weight 
18.5-24.9 
Overweight 
25-29.9 
Obese 
Class I 
30-34.9 
Obese 
Class II 
35-39.9 
Obese 
Class III 
≥40 
   Father Acknowledged on Birth Certificate* 
      Yes 84.8% 88.7% 87.7% 85.9% 84.6% 81.9% 
      No 15.2% 11.3% 12.3% 14.1% 15.4% 18.1% 
   ICE† for Race and Ethnicity Plus Income 
      Bottom quartile 29.2% 26.8% 32.9% 36.8% 38.8% 43.3% 
      Second quartile 26.2% 25.5% 27.0% 27.4% 27.3% 26.1% 
      Third quartile 25.2% 25.0% 23.8% 22.8% 22.4% 21.1% 
      Fourth quartile 19.4% 22.7% 16.3% 13.0% 11.4% 9.5% 
Medical Factors 
   Birth Order and History of Cesarean Delivery 
      1st delivery 52.1% 46.7% 39.0% 35.2% 34.6% 33.6% 
      2nd or 3rd, without previous cesarean delivery 32.3% 33.0% 33.1% 31.6% 29.2% 26.0% 
      2nd or 3rd, with previous cesarean delivery 8.9% 12.7% 16.5% 19.3% 21.5% 24.7% 
      4th or later, without previous cesarean delivery 5.4% 5.9% 8.6% 10.1% 10.1% 10.3% 
      4th or later, with previous cesarean delivery 1.4% 1.7% 2.8% 3.9% 4.6% 5.4% 
   Diabetes 
      Yes 3.6% 4.8% 8.4% 12.6% 16.4% 20.6% 
      No 96.4% 95.2% 91.6% 87.4% 83.6% 79.4% 
   Hypertension 
      Yes 4.4% 6.0% 10.2% 15.1% 20.1% 28.6% 
      No 95.6% 94.0% 89.8% 84.9% 79.9% 71.4% 
Individual Health Service Factors 
   Adequacy of Prenatal Care (GINDEX§) 
      Intensive/Adequate 32.7% 36.1% 35.4% 35.6% 36.3% 36.9% 
      Intermediate 37.7% 37.0% 37.2% 37.0% 36.7% 36.2% 
      Inadequate 22.0% 20.3% 20.7% 20.8% 20.7% 20.7% 
      No care 1.5% 1.0% 1.0% 1.0% 0.9% 1.0% 
      Unknown 6.1% 5.7% 5.8% 5.6% 5.4% 5.2% 
NOTE: All values are significant at a χ2 p-value of <0.0001 
* Based on whether or not the father’s age is reported on the birth certificate 
† Index of Concentration at the Extremes 
§ Graduated Prenatal Care Utilization Index 
¶ Neonatal Intensive Care Unit  
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Table 3, continued. Severe Maternal Morbidity, Individual, and Hospital Factors by Body Mass Index in Florida, 2007-2014 
Factors 
Prepregnancy Body Mass Index (BMI) (kg/m2) 
Underweight 
≤18.5 
Normal 
Weight 
18.5-24.9 
Overweight 
25-29.9 
Obese 
Class I 
30-34.9 
Obese 
Class II 
35-39.9 
Obese 
Class III 
≥40 
 N = 66,662 N = 672,775 N = 345,196 N = 171,939 N = 77,433 N = 51,121 
 % % % % % % 
Hospital Health Service 
   Level of NICU¶ and Birth Volume Quartile 
      Level I, Bottom quartile 5.8% 4.9% 5.3% 5.9% 6.2% 6.2% 
      Level I, Second-third quartile 16.5% 16.1% 16.2% 16.7% 16.8% 16.4% 
      Level I, Top quartile 2.6% 2.7% 2.7% 2.7% 2.8% 2.5% 
      Level II, Bottom quartile 0.4% 0.4% 0.4% 0.4% 0.4% 0.4% 
      Level II, Second-third quartile 20.0% 19.4% 20.0% 20.0% 19.8% 18.9% 
      Level II, Top quartile 9.6% 10.2% 10.2% 10.0% 9.7% 8.8% 
      Level III, Second-third quartile 5.8% 6.3% 5.8% 5.4% 5.3% 5.3% 
      Level III, Top quartile 39.2% 39.9% 39.4% 38.9% 39.0% 41.6% 
   Hospital Certified Nurse Midwife Birth Percentage Quartile 
      Bottom quartile 50.2% 51.2% 50.9% 49.9% 49.2% 48.3% 
      Second-third quartile 35.9% 35.6% 35.5% 36.3% 37.4% 38.7% 
      Top quartile 13.9% 13.1% 13.6% 13.8% 13.4% 13.0% 
   Hospital Medicaid Birth Percentage Quartile 
      Bottom quartile 38.5% 43.7% 39.5% 36.4% 35.2% 32.1% 
      Second-third quartile 53.0% 48.8% 51.6% 53.9% 54.8% 57.1% 
      Top quartile 8.5% 7.6% 8.9% 9.7% 10.0% 10.8% 
NOTE: All values are significant at a χ2 p-value of <0.0001 
* Based on whether or not the father’s age is reported on the birth certificate 
† Index of Concentration at the Extremes 
§ Graduated Prenatal Care Utilization Index 
¶ Neonatal Intensive Care Unit 
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Table 3, continued. Severe Maternal Morbidity, Individual Factors, and Hospital Factors by Body Mass Index in Florida, 
2007-2014 
Factors 
Prepregnancy Body Mass Index (BMI) (kg/m2) 
Underweight 
≤18.5 
Normal 
Weight 
18.5-24.9 
Overweight 
25-29.9 
Obese 
Class I 
30-34.9 
Obese 
Class II 
35-39.9 
Obese 
Class III 
≥40 
 N = 66,662 N = 672,775 N = 345,196 N = 171,939 N = 77,433 N = 51,121 
 % % % % % % 
   Florida Geographic Region 
      Northwestern 6.8% 6.0% 6.1% 6.8% 7.5% 8.5% 
      Northeastern 11.6% 11.3% 11.8% 12.8% 14.4% 16.1% 
      Central 26.8% 24.5% 24.3% 25.2% 26.1% 25.5% 
      Western 23.2% 22.5% 21.7% 22.0% 22.1% 22.5% 
      Eastern 17.7% 19.4% 20.0% 19.1% 17.9% 16.6% 
      Southern 13.9% 16.3% 16.1% 14.2% 12.1% 10.8% 
   Year 
      2007 13.9% 13.6% 12.7% 12.7% 12.0% 11.7% 
      2008 13.1% 12.8% 12.3% 12.1% 11.6% 11.4% 
      2009 12.4% 12.4% 12.2% 11.9% 12.0% 11.8% 
      2010 12.5% 12.5% 12.5% 12.3% 12.3% 12.4% 
      2011 12.7% 12.5% 12.6% 12.8% 12.8% 13.1% 
      2012 12.4% 12.3% 12.5% 12.6% 12.8% 13.1% 
      2013 11.6% 11.8% 12.5% 12.6% 13.0% 12.8% 
      2014 11.5% 12.0% 12.8% 13.1% 13.4% 13.7% 
NOTE: All values are significant at a χ2 p-value of <0.0001 
* Based on whether or not the father’s age is reported on the birth certificate 
† Index of Concentration at the Extremes 
§ Graduated Prenatal Care Utilization Index 
¶ Neonatal Intensive Care Unit 
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Table 4. Unadjusted and Adjusted Odds Ratios of Severe Maternal Morbidity in Florida, 2007-2014 
Factors 
Unadjusted Risk Adjusted Risk* 
Adjusted Risk 
(Adjusting for 
Diabetes) 
Adjusted Risk 
(Adjusting for 
Hypertension) 
Adjusted Risk 
(Adjusting for 
Diabetes and 
Hypertension) 
OR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI 
Prepregnancy Body Mass Index (BMI) (kg/m2) 
      Underweight (≤18.5) 1.13 (1.06, 1.20) 1.14 (1.07, 1.22) 1.15 (1.08, 1.22) 1.17 (1.09, 1.24) 1.17 (1.10, 1.24) 
      Normal weight (18.5-24.9) REF REF REF REF REF REF REF REF REF REF 
      Overweight (25-29.9) 1.04 (1.00, 1.07) 0.96 (0.92, 0.99) 0.95 (0.92, 0.98) 0.91 (0.88, 0.95) 0.91 (0.88, 0.94) 
      Obese class I (30-34.9) 1.07 (1.02, 1.12) 0.93 (0.89, 0.97) 0.91 (0.87, 0.95) 0.85 (0.81, 0.88) 0.84 (0.80, 0.87) 
      Obese class II (35-39.9) 1.14 (1.08, 1.21) 0.95 (0.90, 1.01) 0.92 (0.87, 0.98) 0.83 (0.78, 0.88) 0.81 (0.77, 0.87) 
      Obese class III (≥40) 1.26 (1.18, 1.35) 0.99 (0.92, 1.05) 0.94 (0.88, 1.01) 0.79 (0.74, 0.85) 0.77 (0.72, 0.83) 
Sociodemographic Factors 
   Age (years) 
      Younger than 20 1.07 (1.02, 1.13) 0.93 (0.88, 0.98) 0.93 (0.88, 0.99) 0.93 (0.88, 0.99) 0.94 (0.89, 0.99) 
      20-34 REF REF REF REF REF REF REF REF REF REF 
      35 and older 1.40 (1.35, 1.45) 1.42 (1.37, 1.48) 1.40 (1.34, 1.45) 1.35 (1.30, 1.40) 1.34 (1.29, 1.39) 
   Race and Ethnicity 
      Non-Hispanic white REF REF REF REF REF REF REF REF REF REF 
      Non-Hispanic black 1.92 (1.85, 1.99) 1.64 (1.57, 1.71) 1.64 (1.58, 1.72) 1.61 (1.54, 1.68) 1.61 (1.54, 1.68) 
      Hispanic 1.34 (1.29, 1.39) 1.20 (1.15, 1.25) 1.19 (1.15, 1.24) 1.22 (1.17, 1.27) 1.21 (1.17, 1.26) 
      Other 1.24 (1.16, 1.33) 1.19 (1.11, 1.28) 1.17 (1.08, 1.25) 1.22 (1.13, 1.31) 1.20 (1.12, 1.29) 
   Education 
      Less than high school 1.24 (1.19, 1.29) 1.10 (1.05, 1.15) 1.10 (1.05, 1.15) 1.10 (1.05, 1.15) 1.09 (1.05, 1.15) 
      High school graduate or GED 1.16 (1.13, 1.20) 1.07 (1.03, 1.11) 1.07 (1.03, 1.11) 1.06 (1.03, 1.10) 1.06 (1.03, 1.10) 
      Some college or greater REF REF REF REF REF REF REF REF REF REF 
   Insurance Status 
      Medicaid 1.26 (1.23, 1.30) 1.09 (1.05, 1.13) 1.09 (1.05, 1.13) 1.09 (1.06, 1.13) 1.09 (1.06, 1.13) 
      Private REF REF REF REF REF REF REF REF REF REF 
      Self-pay 1.01 (0.93, 1.10) 0.93 (0.86, 1.02) 0.93 (0.86, 1.02) 0.95 (0.87, 1.03) 0.95 (0.87, 1.03) 
      Other 1.41 (1.24, 1.46) 1.21 (1.07, 1.37) 1.21 (1.07, 1.37) 1.21 (1.07, 1.37) 1.21 (1.06, 1.37) 
   Father Acknowledged on Birth Certificate† 
      Yes REF REF REF REF REF REF REF REF REF REF 
      No 1.41 (1.35, 1.46) 1.17 (1.12, 1.21) 1.17 (1.12, 1.22) 1.16 (1.12, 1.21) 1.16 (1.12, 1.21) 
   ICE§ for Race and Ethnicity Plus Income 
      Bottom quartile 1.51 (1.44, 1.58) 1.13 (1.07, 1.19) 1.12 (1.07, 1.18) 1.11 (1.06, 1.17) 1.11 (1.05, 1.17) 
      Second quartile 1.13 (1.07, 1.18) 1.04 (0.99, 1.10) 1.04 (0.99, 1.09) 1.03 (0.98, 1.09) 1.03 (0.98, 1.08) 
      Third quartile 1.05 (0.99, 1.10) 1.03 (0.98, 1.09) 1.03 (0.98, 1.09) 1.03 (0.98, 1.08) 1.03 (0.98, 1.08) 
      Fourth quartile REF REF REF REF REF REF REF REF REF REF 
Models are adjusted for all variables in the tables as well as hospital health service factors. 
OR = odds ratio; AOR = adjusted odds ratio 
CI = confidence interval 
* Significant adjusted odds ratios at p-value <0.05 are bolded 
† Based on whether or not the father’s age is reported on the birth certificate 
§ Index of Concentration at the Extremes 
¶ Graduated Prenatal Care Utilization Index  
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Table 4, continued. Unadjusted and Adjusted Odds Ratios of Severe Maternal Morbidity in Florida, 2007-2014 
Factors 
Unadjusted Risk Adjusted Risk 
Adjusted Risk 
(Adjusting for 
Diabetes) 
Adjusted Risk 
(Adjusting for 
Hypertension) 
Adjusted Risk 
(Adjusting for 
Diabetes and 
Hypertension) 
OR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI 
Medical Factors 
   Birth Order and History 
      1st delivery 1.46 (1.41, 1.51) 1.53 (1.48, 1.59) 1.53 (1.47, 1.59) 1.46 (1.40, 1.51) 1.46 (1.40, 1.51) 
      2nd or 3rd, without previous cesarean delivery REF REF REF REF REF REF REF REF REF REF 
      2nd or 3rd, with previous cesarean delivery 2.11 (2.02, 2.20) 2.08 (1.99, 2.17) 2.07 (1.98, 2.16) 2.07 (1.99, 2.16) 2.07 (1.98, 2.16) 
      4th or later, without previous cesarean delivery 1.60 (1.51, 1.70) 1.37 (1.29, 1.45) 1.36 (1.29, 1.44) 1.36 (1.28, 1.44) 1.36 (1.28, 1.44) 
      4th or later, with previous cesarean delivery 4.07 (3.83, 4.33) 3.38 (3.18, 3.60) 3.36 (3.16, 3.57) 3.35 (3.15, 3.57) 3.34 (3.14, 3.55) 
   Diabetes 
      Yes         1.28 (1.23, 1.34)     1.17 (1.11, 1.22) 
      No     REF REF   REF REF 
   Hypertension 
      Yes             3.36 (3.16, 3.57) 2.14 (2.06, 2.22) 
      No       REF REF REF REF 
Individual Health Service Factors 
   Adequacy of Prenatal Care (GINDEX¶) 
      Intensive/Adequate REF REF REF REF REF REF REF REF REF REF 
      Intermediate 0.92 (0.89, 0.95) 0.89 (0.85, 0.92) 0.90 (0.87, 0.93) 0.92 (0.89, 0.95) 0.92 (0.89, 0.95) 
      Inadequate 0.98 (0.94, 1.01) 0.91 (0.88, 0.95) 0.92 (0.89, 0.96) 0.94 (0.90, 0.97) 0.94 (0.90, 0.98) 
      No care 1.83 (1.65, 2.04) 1.55 (1.40, 1.72) 1.58 (1.42, 1.75) 1.58 (1.42, 1.75) 1.60 (1.44, 1.77) 
      Unknown 1.18 (1.12, 1.25) 1.09 (1.03, 1.15) 1.09 (1.03, 1.16) 1.09 (1.04, 1.17) 1.11 (1.05, 1.18) 
Year 
      2007 REF REF REF REF REF REF REF REF REF REF 
      2008 1.16 (1.09, 1.23) 1.13 (1.06, 1.20) 1.13 (1.06, 1.20) 1.13 (1.06, 1.19) 1.13 (1.06, 1.19) 
      2009 1.25 (1.18, 1.33) 1.23 (1.16, 1.30) 1.23 (1.16, 1.30) 1.22 (1.15, 1.29) 1.22 (1.15, 1.29) 
      2010 1.30 (1.22, 1.38) 1.26 (1.19, 1.34) 1.26 (1.19, 1.34) 1.25 (1.18, 1.33) 1.25 (1.18, 1.33) 
      2011 1.37 (1.29, 1.45) 1.32 (1.24, 1.40) 1.32 (1.24, 1.40) 1.31 (1.23, 1.39) 1.31 (1.23, 1.39) 
      2012 1.40 (1.31, 1.48) 1.34 (1.27, 1.43) 1.34 (1.26, 1.42) 1.33 (1.25, 1.41) 1.33 (1.25, 1.41) 
      2013 1.41 (1.33, 1.50) 1.37 (1.29, 1.45) 1.36 (1.29, 1.45) 1.36 (1.28, 1.44) 1.36 (1.28, 1.44) 
      2014 1.52 (1.43, 1.61) 1.47 (1.39, 1.56) 1.47 (1.39, 1.56) 1.46 (1.38, 1.55) 1.46 (1.38, 1.55) 
Models are adjusted for all variables in the tables as well as hospital health service factors. 
OR = odds ratio; AOR = adjusted odds ratio 
CI = confidence interval 
* Significant adjusted odds ratios at p-value <0.05 are bolded 
† Based on whether or not the father’s age is reported on the birth certificate 
§ Index of Concentration at the Extremes 
¶ Graduated Prenatal Care Utilization Index 
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Table 5. Adjusted Odds Ratios of the Most Common Severe Maternal Morbidities in Florida, 2007-2014 
Factors 
Prepregnancy Body Mass Index (BMI) (kg/m2) 
Underweight 
≤18.5 
Normal 
Weight 
18.5-24.9 
Overweight 
25-29.9 
Obese 
Class I 
30-34.9 
Obese 
Class II 
35-39.9 
Obese 
Class III 
≥40 
AOR* 95% CI AOR* 95% CI AOR* 95% CI AOR* 95% CI AOR* 95% CI AOR* 95% CI 
Severe maternal morbidity 1.14 (1.07, 1.22) REF REF 0.96 (0.92, 0.99) 0.93 (0.89, 0.97) 0.95 (0.90, 1.01) 0.98 (0.92, 1.05) 
Blood transfusion 1.20 (1.11, 1.30) REF REF 0.93 (0.89, 0.97) 0.85 (0.81, 0.90) 0.86 (0.80, 0.93) 0.82 (0.75, 0.90) 
All morbidities, except blood transfusion 1.02 (0.92, 1.13) REF REF 1.03 (0.95, 1.05) 1.03 (0.96, 1.10) 1.08 (0.99, 1.17) 1.23 (1.12, 1.35) 
Disseminated intravascular coagulation 0.94 (0.79, 1.12) REF REF 0.80 (0.79, 0.94) 0.80 (0.71, 0.89) 0.76 (0.64, 0.91) 0.64 (0.51, 0.79) 
Heart failure during procedure or surgery 0.91 (0.74, 1.11) REF REF 1.10 (1.01, 1.20) 1.10 (0.99, 1.23) 1.21 (1.04, 1.40) 1.28 (1.08, 1.51) 
Hysterectomy 1.06 (0.77, 1.45) REF REF 1.03 (0.89, 1.19) 1.11 (0.94, 1.32) 0.99 (0.78, 1.28) 1.07 (0.82, 1.40) 
Adult respiratory distress syndrome 1.15 (0.83, 1.60) REF REF 1.03 (0.86, 1.23) 1.06 (0.84, 1.32) 0.93 (0.67, 1.29) 2.37 (1.83, 3.07) 
Ventilation 1.06 (0.74, 1.51) REF REF 1.12 (0.93, 1.34) 1.07 (0.84, 1.36) 1.41 (1.06, 1.88) 2.54 (1.97, 3.28) 
Other 1.08 (0.88, 1.33) REF REF 1.03 (0.93, 1.14) 1.14 (0.99, 1.29) 1.29 (1.09, 1.52) 1.29 (1.09, 1.52) 
Model adjusted for: sociodemographic factors, medical risk factors, individual health service factors, hospital health service factors, and year. 
OR = odds ratio 
AOR = adjusted odds ratio 
CI = confidence interval 
* Significant adjusted odds ratios at a p-value <0.05 are bolded 
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Table 6. Factors Examined in Multivariable Regression Modeling 
Characteristics Data Source 
Sociodemographic Factors 
Maternal Age 
     <20 years 
     20-34 years 
     ≥35 years 
Birth Certificate 
Maternal Race and Ethnicity 
     Non-Hispanic White 
     Non-Hispanic Black 
     Hispanic 
     Other 
Birth Certificate 
Maternal Education 
     Less Than High School 
     High School Diploma/GED 
     Some College or greater 
Birth Certificate 
Insurance Status 
     Medicaid 
     Private 
     Self-pay 
     Other 
Hospital Discharge 
Father Acknowledged on Birth Record 
     Yes 
     No 
Birth Certificate 
Medical Risk Factors 
Prepregnancy Body Mass Index (kg/m2) 
     Underweight (18.5 and less) 
     Normal weight (18.5–24.9) 
     Overweight (25–29.9) 
     Obese class I (30–34.9) 
     Obese class II (35-39.9) 
     Obese class III (40 and greater) 
Birth Certificate 
Birth Order and History of Cesarean Delivery 
     First delivery 
     Second or third, without previous cesarean delivery 
     Second or third, with previous cesarean delivery 
     Fourth or later, without previous cesarean delivery 
     Fourth or later, with previous cesarean delivery 
Birth Certificate 
Plurality 
     Singleton 
     Twin 
     Triplet 
Birth Certificate 
Maternal Diabetes Hospital Discharge, Birth Certificate 
Maternal Hypertension Hospital Discharge, Birth Certificate 
Individual Health Service Factors  
Adequacy of Prenatal Care (GINDEX) 
     Intensive/Adequate 
     Intermediate 
     Inadequate 
     No Care 
     Unknown 
Birth Certificate 
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Table 6, continued. Factors Examined in Multivariable Regression Modeling 
Hospital Health Service Factors 
Level of NICU and Annual Hospital Birth Volume Quartile 
     Level I; Bottom quartile 
     Level I; Second-third quartile 
     Level I; Top quartile 
     Level II; Bottom quartile 
     Level II; Second-third quartile 
     Level II; Top quartile 
     Level III; Second-third quartile 
     Level III; Top quartile 
Florida Agency for Health Care Administration 
Birth Certificate 
Hospital Percentage of Medicaid Births Quartile 
     Bottom quartile 
     Second-third quartile 
     Fourth quartile 
Hospital Discharge 
Hospital Percentage of Certified Nurse Midwife Births 
     Bottom quartile 
     Second-third quartile 
     Fourth quartile 
Birth Certificate 
Florida Geographic Location 
     Northwestern 
     Northeastern 
     Central 
     Western 
     Eastern 
     Southern 
Birth Certificate 
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Table 7. Obstetric Hemorrhage and Uterine Rupture, ICD-9-CM2,3 
 Condition ICD-9-CM Codes 
1. Previa 641.0x, 641.1x 
2. Abruption 641.2x 
3. Antepartum hemorrhage 641.3x, 641.8x, 641.9x 
4. Postpartum hemorrhage 666.xx 
5. Uterine rupture 665.0x, 665.1x 
Note: ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification 
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Table 8. Severe Maternal Morbidity Rates for the Most Common Morbidities in Florida, 2005 and 2014 
 Severe Maternal Morbidity   
 2014* 2005
†
   
Morbidity N (Rate
§
) N (Rate
§
) RR (95% CI) Rate Difference (95% CI) 
Total Severe Maternal Morbidity 3,498 (19.3) 2,164 (11.7) 1.65 (1.56, 1.74) 7.6 (6.8, 8.4) 
Severe Maternal Morbidity, Not Including Blood Transfusions 1,344 (7.4) 1,346 (7.3) 1.02 (0.94, 1.10) 0.1 (-0.4, 0.7) 
Blood Transfusions 2,493 (13.8) 993 (5.4) 2.56 (2.38, 2.76) 8.4 (7.8, 9.0) 
Disseminated Intravascular Coagulation 481 (2.7) 380 (2.1) 1.29 (1.13, 1.48) 0.6 (0.3, 0.9) 
Heart Failure During Procedure or Surgery 403 (2.2) 515 (2.8) 0.80 (0.70, 0.91) -0.6 (-0.9, -0.2) 
Hysterectomy 178 (1.0) 147 (0.8) 1.24 (0.99, 1.54) 0.2 (0.0, 0.4) 
Adult Respiratory Distress Syndrome 96 (0.5) 110 (0.6) 0.89 (0.68, 1.17) -0.1 (-0.2, 0.1) 
Ventilation 128 (0.7) 85 (0.5) 1.54 (1.17, 2.02) 0.2 (0.1, 0.4) 
Note: CI = confidence interval; RR = rate ratio 
* Among 181,187 births 
† Among 184, 811 births 
§ Rate per 1,000 live births 
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Table 9. Contribution of Sociodemographic, Medical, Individual Health Service, and Hospital Health Service Factors to the 
Increase in the Rate of Severe Maternal Morbidity in Florida, 2005 and 2014 
 Birth Distribution 
 
SMM Rate per 1,000 Live Births 
 Excess SMM 
Attributable to 
Distributional 
Difference* 
 
Excess SMM 
Attributable to 
Rate Difference† 
 
Total 
Excess 
SMM 
Factor 
2014 
(%) 
2005 
(%) 
Prevalence 
Rate Difference 
(95% CI) 
 
2014 2005 
Rate Difference 
(95% CI) 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Severe Maternal Morbidity 100.0 100.0   19.3 11.7 7.6 (6.8, 8.4)         
Sociodemographic Factors                
   Age                
     Younger than 20 years 5.9 10.4 -4.48 (-4.66, -4.31)  21.7 10.3 11.3 (8.2, 14.4)  -0.7 -9.4  0.9 12.2  0.2 
     20-34 years 78.2 75.1 3.08 (2.80, 3.35)  17.9 10.9 7.0 (6.1, 7.9)  0.4 5.8  5.4 70.6  5.8 
     35 years and older 15.9 14.5 1.41 (1.18, 1.64)  25.3 16.8 8.5 (6.1, 10.8)  0.3 3.9  1.3 16.9  1.6 
     TOTAL 100.0 100.0   19.3 11.7   0.0 0.3  7.6 99.7  7.6 
   Race and Ethnicity                
     Non-Hispanic White 45.7 49.2 -3.28 (-3.80, -3.15)  15.6 9.2 6.3 (5.3, 7.4)  -0.4 -5.7  3.0 39.6  2.6 
     Non-Hispanic Black 18.7 17.8 0.91 (0.66, 1.16)  28.8 17.2 11.6 (9.3, 13.8)  0.2 2.8  2.1 27.8  2.3 
     Hispanic 31.1 28.8 2.26 (1.96, 2.56)  19.3 12.4 6.9 (5.4, 8.4)  0.4 4.7  2.1 27.2  2.4 
     Other 4.5 4.2 0.30 (0.17, 0.43)  18.0 12.9 5.2 (1.3, 9.0)  0.0 0.6  0.2 2.9  0.3 
     TOTAL 100.0 100.0   19.3 11.7   0.2 2.4  7.4 97.6  7.6 
   Education                
     Less than high school 12.5 19.1 -6.52 (-6.76, -6.29)  24.7 13.0 11.7 (9.4, 14.1)  -1.2 -16.2  1.9 24.4  0.6 
     High school graduate or GED 32.2 32.0 0.20 (-0.10, 0.51)  20.7 11.6 9.1 (7.6, 10.5)  0.0 0.4  2.9 38.3  2.9 
     Some college or greater 53.3 49.0 6.32 (5.99, 6.64)  17.3 11.3 6.0 (4.9, 7.1)  0.9 11.9  3.1 41.2  4.0 
     TOTAL 100.0 100.0   19.3 11.7   -0.3 -3.9  7.9 103.9  7.6 
   Insurance Status                
     Medicaid 53.0 46.2 6.53 (6.20, 6.85)  22.2 12.2 9.9 (8.8, 11.1)  1.1 14.8  4.9 65.0  6.1 
     Private 44.0 48.2 -4.21 (-4.53, -3.89)  16.0 11.4 4.6 (3.5, 5.7)  -0.6 -7.6  2.1 27.9  1.5 
     Self-pay 2.3 4.0 -1.67 (-1.79, -1.56)  15.3 8.2 7.1 (2.9, 11.4)  -0.2 -2.6  0.2 3.0  0.0 
     Other 0.7 1.4 -0.64 (-0.71, -0.58)  24.6 15.5 9.1 (-0.6, 18.8)  -0.1 -1.7  0.1 1.2  0.0 
     TOTAL 100.0 100.0   19.3 11.7   0.2 2.9  7.4 97.1  7.6 
   Father Acknowledged on Birth Certificate              
     Yes 86.7 91.4 -4.75 (-4.94, -4.54)  18.1 11.4 6.7 (5.9, 7.5)  -0.7 -9.2  6.0 78.7  5.3 
     No 13.3 8.6 4.75 (4.54, 4.94)  27.1 15.0 12.0 (9.2, 14.8)  1.0 13.2  1.3 17.4  2.3 
     TOTAL 100.0 100.0   19.3 11.7   0.3 3.9  7.3 96.1  7.6 
Note: CI = confidence interval; RR = rate ratio; SMM = severe maternal morbidity; BMI = body mass index 
* Determined by the Kitagawa method, the difference between the two time periods in percentage for a given factor multiplied by the average 
severe maternal morbidity rate for the two time periods for that factor. 
† Determined by the Kitagawa method, the difference in rates of severe maternal morbidity between the two time periods for a given factors 
multiplied by the average percentage of that factor for the two time periods 
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Table 9, continued. Contribution of Sociodemographic, Medical, Individual Health Service, and Hospital Health Service 
Factors to the Increase in the Rate of Severe Maternal Morbidity in Florida, 2005 and 2014 
 Birth Distribution 
 
SMM Rate per 1,000 Live Births 
 Excess SMM 
Attributable to 
Distributional 
Difference* 
 
Excess SMM 
Attributable to 
Rate Difference† 
 
Total 
Excess 
SMM 
Factor 
2014 
(%) 
2005 
(%) 
Prevalence 
Rate Difference 
(95% CI) 
 
2014 2005 
Rate Difference 
(95% CI) 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Medical Factors                
   Prepregnancy BMI (kg/m2)                
     Underweight (18.5 and less) 4.4 5.3 -0.92 (-1.06, -0.78)  20.3 11.5 8.8 (5.1, 12.6)  -0.1 -1.9  0.4 5.6  0.3 
     Normal weight (18.5-24.9) 46.8 51.8 -5.00 (-5.32, -4.68)  18.5 11.2 7.3 (6.2, 8.4)  -0.7 -9.8  3.6 47.4  2.9 
     Overweight (25-29.9) 25.6 23.6 1.93 (1.66, 2.21)  19.9 11.9 8.1 (6.5, 9.7)  0.3 4.0  2.0 26.1  2.3 
     Obese class I (30-34.9) 13.1 11.1 1.90 (1.69, 2.12)  19.3 12.9 6.4 (4.0, 8.7)  0.3 4.0  0.8 10.2  1.1 
     Obese class II (35-29.9) 6.1 4.9 1.17 (1.03, 1.32)  21.2 13.8 7.4 (3.8, 11.0)  0.2 2.7  0.4 5.3  0.6 
     Obese class III (40 and higher) 4.1 3.2 0.91 (0.78, 1.03)  21.3 12.4 8.9 (4.6, 13.2)  0.2 2.0  0.3 4.3  0.5 
     TOTAL 100.0 100.0   19.3 11.7 7.6  0.1 1.1  7.5 98.9  7.6 
   Birth Order and History of Cesarean Delivery              
     First delivery 40.6 41.9 -1.28 (-1.60, -0.96)  18.5 11.1 7.4 (6.1, 8.6)  -0.2 -2.5  3.0 40.0  2.9 
     2nd or 3rd, w/o previous cesarean 32.5 36.0 -3.51 (-3.82, -3.20)  14.0 8.8 5.2 (4.0, 6.4)  -0.4 -5.3  1.8 23.5  1.4 
     2nd or 3rd, w/ previous cesarean 16.1 12.6 3.44 (3.21, 3.66)  23.7 17.9 5.7 (3.3, 8.2)  0.7 9.4  0.8 10.8  1.5 
     4th or later, w/o  previous cesarean 7.9 7.4 0.50 (0.33, 0.67)  24.8 14.5 10.3 (7.0, 13.5)  0.1 1.3  0.8 10.3  0.9 
     4th or later, w/ previous cesarean 3.0 2.1 0.85 (0.75, 0.96)  50.0 26.0 24.0 (16.4, 31.7)  0.3 4.2  0.6 8.1  0.9 
     TOTAL 100.0 100.0   19.3 11.7 7.6  0.5 7.2  7.0 92.8  7.6 
   Plurality                    
     Singleton 96.6 96.8 -0.16 (-0.27, -0.04)  17.6 10.8 6.8 (6.0, 7.6)  0.0 -0.3  6.6 86.3  6.5 
     Twin 3.3 3.1 0.20 (0.90, 3.20)  65.9 36.8 29.0 (21.1, 37.0)  0.1 1.4  0.9 12.2  1.0 
     Triplet 0.1 0.1 -0.04 (-0.07, -0.02)  142.9 76.6 66.2 (5.2, 127.3)  0.0 -0.6  0.1 1.0  0.0 
     TOTAL     19.3  7.6  0.0 0.5  7.6 99.6  7.6 
Individual Health Service Factors                
   Adequacy of Prenatal Care (GINDEX)                   
     Intensive/Adequate 35.9 38.6 -2.67 (-2.98, -2.36)  19.6 12.6 7.0 (5.7, 8.4)  -0.4 0.0  2.6 34.6  2.2 
     Intermediate 37.4 34.4 3.03 (2.72, 3.34)  17.9 10.5 7.4 (6.1, 8.6)  0.4 5.7  2.6 34.7  3.1 
     Inadequate 21.1 18.1 2.99 (2.73, 3.25)  19.1 10.3 8.8 (7.1, 10.6)  0.4 5.8  1.7 22.7  2.2 
     No care 1.0 1.0 -0.03 (-0.09, 0.04)  42.0 27.1 14.9 (3.2, 26.7)  0.0 -0.1  0.2 2.0  0.1 
     Unknown 4.6 7.9 -3.32 (-3.48, -3.16)  24.2 13.8 10.5 (6.6, 14.3)  -0.6 -8.3  0.7 8.6  0.0 
     TOTAL 100.0 100.0   19.3 11.7 7.6  -0.2 -2.7  7.8 102.7  7.6 
Note: CI = confidence interval; RR = rate ratio; SMM = severe maternal morbidity; BMI = body mass index 
* Determined by the Kitagawa method, the difference between the two time periods in percentage for a given factor multiplied by the average 
severe maternal morbidity rate for the two time periods for that factor. 
† Determined by the Kitagawa method, the difference in rates of severe maternal morbidity between the two time periods for a given factors 
multiplied by the average percentage of that factor for the two time periods 
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Table 9, continued. Contribution of Sociodemographic, Medical, Individual Health Service, and Hospital Health Service 
Factors to the Increase in the Rate of Severe Maternal Morbidity in Florida, 2005 and 2014 
 Birth Distribution 
 
SMM Rate per 1,000 Live Births 
 Excess SMM 
Attributable to 
Distributional 
Difference* 
 
Excess SMM 
Attributable to 
Rate Difference† 
 
Total 
Excess 
SMM 
Factor 
2014 
(%) 
2005 
(%) 
Prevalence 
Rate Difference 
(95% CI) 
 
2014 2005 
Rate Difference 
(95% CI) 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Hospital Health Service Factors                
   Level of NICU and Birth Volume Quartile               
     Level I, Bottom 5.0 6.4 -1.37 (-1.52, -1.22)  19.7 11.9 7.8 (4.4, 11.3)  -0.2 -2.8  0.4 5.9  0.2 
     Level I, Second-Third 16.2 21.2 -4.94 (-5.19, -4.69)  14.8 7.2 7.5 (5.9, 9.2)  -0.5 -7.2  1.4 18.5  0.9 
     Level I, Top 0.0 1.2 -1.21 (-1.26, -1.16)  … 8.5      … …  … …  … 
     Level II, Bottom 0.3 0.0 0.26 (0.24, 0.29)  8.4 …      … …  … …  … 
     Level II, Second-Third 19.0 19.1 -0.04 (-0.30, 0.21)  17.8 10.3 7.5 (5.8, 9.3)  0.0 -0.1  1.4 18.8  1.4 
     Level II, Top 11.6 10.8 0.79 (0.59, 1.00)  13.2 10.7 2.5 (0.4, 4.6)  0.1 1.2  0.3 3.7  0.4 
     Level III, Second-Third 8.5 2.0 6.49 (6.35, 6.63)  22.0 8.8 13.2 (9.4, 17.0)  1.0 13.2  0.7 9.1  1.7 
     Level III, Top 39.4 39.4 0.02 (-0.34, 0.34)  23.1 15.3 7.8 (6.4, 9.3)  0.0 0.1  3.1 40.7  3.1 
     TOTAL 100.0 100.0   19.3 11.7 7.6  0.3 4.4  7.3 96.7  7.7 
   Certified Nurse Midwife Percentage Quartile              
     Bottom 52.2 48.5 3.66 (3.34, 3.99)  19.6 13.5 6.1 (4.9, 7.3)  0.6 8.0  3.1 40.4  3.7 
     Second-Third 38.3 38.9 -0.58 (-0.89, -0.26)  18.7 10.4 8.3 (7.0, 9.5)  -0.1 -1.1  3.2 42.0  3.1 
     Top 9.5 12.6 -3.08 (-3.29, -2.88)  20.4 8.9 11.5 (9.1, 13.9)  -0.5 -5.9  1.3 16.7  0.8 
     TOTAL 100.0 100.0   19.3 11.7 7.6  0.1 0.9  7.5 99.1  7.6 
   Medicaid Birth Percentage Quartile               
     Bottom 40.2 31.0 9.22 (8.91, 9.53)  17.2 11.9 5.2 (3.9, 6.)5  1.3 17.7  1.9 24.5  3.2 
     Second-Third 53.7 57.3 -3.63 (-3.95, -3.31)  19.4 10.4 9.1 (8.0, 10.1)  -0.5 -7.1  5.0 66.3  4.5 
     Top 6.1 11.7 -5.59 (-5.77, -5.41)  32.3 17.7 14.6 (10.9, 18.3)  -1.4 -18.4  1.3 17.1  -0.1 
     TOTAL 100.0 100.0   19.3 11.7 7.6  -0.6 -7.9  8.2 107.9  7.6 
   Florida Geographic Location                
     Northwestern 5.3 7.5 -2.22 (-2.38, -2.06)  24.0 11.8 12.1 (8.6, 15.7)  -0.4 -5.2  0.8 10.2  0.4 
     Northeastern 12.2 11.5 0.63 (0.42, 0.83)  19.9 9.3 10.6 (8.3, 12.8)  0.1 1.2  1.3 16.5  1.3 
     Central 24.4 24.6 -0.15 (-0.43, 0.13)  15.3 10.1 5.2 (3.8, 6.7)  0.0 -0.3  1.3 16.8  1.3 
     Western 22.6 21.8 0.80 (0.53, 1.07)  17.9 12.4 5.5 (3.8, 7.2)  0.1 1.6  1.2 16.0  1.3 
     Eastern 19.7 19.8 -0.15 (-0.41, 0.11)  22.7 13.4 9.3 (7.4, 11.2)  0.0 -0.4  1.8 24.2  1.8 
     Southern 16.0 14.9 1.09 (0.86, 1.33)  21.2 13.0 8.3 (6.1, 10.4)  0.2 2.5  1.3 16.8  1.5 
     TOTAL 100.0 100.0   19.3 11.7 7.6  0.0 -0.6  7.6 100.6  7.6 
Note: CI = confidence interval; RR = rate ratio; SMM = severe maternal morbidity; BMI = body mass index 
* Determined by the Kitagawa method, the difference between the two time periods in percentage for a given factor multiplied by the average 
severe maternal morbidity rate for the two time periods for that factor. 
† Determined by the Kitagawa method, the difference in rates of severe maternal morbidity between the two time periods for a given factors 
multiplied by the average percentage of that factor for the two time periods 
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Table 10. Contribution of Sociodemographic, Medical, Individual Health Service, and Hospital Health Service Factors to the 
Increase in the Rate of Blood Transfusion in Florida, 2005 and 2014 
Factor 
Birth Distribution 
 
BT Rate per 1,000 Live Births 
 Excess BT 
Attributable to 
Distributional 
Difference* 
 Excess BT 
Attributable to 
Rate 
Difference† 
 
Total 
Excess 
BT 
2014 
(%) 
2005 
(%) 
Prevalence 
Rate Difference 
(95% CI) 
 
2014 2005 
Rate Difference 
(95% CI) 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Blood Transfusions 100.0 100.0   13.8 5.4 8.4 (7.8, 9.0)         
Sociodemographic Factors                
   Age                
     Younger than 20 years 5.9 10.4 -4.48 (-4.66, -4.31)  18.3 5.9 12.4 (9.6, 15.1)  -0.5 -6.5  1.0 12.1  0.5 
     20-34 years 78.2 75.1 3.08 (2.80, 3.35)  13.0 5.1 7.9 (7.2, 8.6)  0.3 3.3  6.0 71.8  6.3 
     35 years and older 15.9 14.5 1.41 (1.18, 1.64)  16.0 6.4 9.6 (7.9, 11.3)  0.2 1.9  1.5 17.4  1.6 
     TOTAL 100.0 100.0   13.8 5.4 8.4  -0.1 -1.3  8.5 101.3  8.4 
   Race and Ethnicity                
     Non-Hispanic White 45.7 49.2 -3.28 (-3.80, -3.15)  10.5 3.6 6.9 (6.1, 7.7)  -0.2 -2.9  3.3 38.8  3.0 
     Non-Hispanic Black 18.7 17.8 0.91 (0.66, 1.16)  22.0 9.0 13.0 (11.1, 14.8)  0.1 1.7  2.4 28.3  2.5 
     Hispanic 31.1 28.8 2.26 (1.96, 2.56)  13.8 6.2 7.6 (6.4, 8.8)  0.2 2.7  2.3 27.2  2.5 
     Other 4.5 4.2 0.30 (0.17, 0.43)  12.5 4.8 7.7 (4.8, 10.5)  0.0 0.3  0.3 3.9  0.4 
     TOTAL 100.0 100.0   13.8 5.4 8.4  0.1 1.8  8.2 98.2  8.4 
   Education                
     Less than high school 12.5 19.1 -6.52 (-6.76, -6.29)  19.5 7.4 12.1 (10.1, 14.1)  -0.9 -10.4  1.9 22.8  1.0 
     High school graduate or GED 32.2 32.0 0.20 (-0.10, 0.51)  15.4 6.1 9.3 (8.1, 10.4)  0.0 0.3  3.0 35.4  3.0 
     Some college or greater 53.3 49.0 6.32 (5.99, 6.64)  11.5 4.1 7.4 (6.6, 8.2)  0.5 5.9  3.9 46.1  4.4 
     TOTAL 100.0 100.0   13.8 5.4 8.4  -0.4 -4.3  8.7 104.3  8.4 
   Insurance Status                
     Medicaid 53.0 46.2 6.53 (6.20, 6.85)  16.8 6.8 10.0 (9.1, 11.0)  0.8 9.2  5.0 59.5  5.8 
     Private 44.0 48.2 -4.21 (-4.53, -3.89)  10.1 4.0 6.1 (5.3, 6.9)  -0.3 -3.5  2.8 33.8  2.5 
     Self-pay 2.3 4.0 -1.67 (-1.79, -1.56)  10.9 4.2 6.7 (3.2, 10.1)  -0.1 -1.5  0.2 2.5  0.1 
     Other 0.7 1.4 -0.64 (-0.71, -0.58)  18.4 9.2 9.3 (1.1, 17.5)  -0.1 -1.1  0.1 1.2  0.0 
     TOTAL 100.0 100.0   13.8 5.4 8.4  0.3 3.1  8.1 96.9  8.4 
   Father Acknowledged on Birth Certificate              
     Yes 86.7 91.4 -4.75 (-4.94, -4.54)  12.7 5.0 7.7 (7.0, 8.3)  -0.4 -5.0  6.8 81.3  6.4 
     No 13.3 8.6 4.75 (4.54, 4.94)  20.8 9.1 11.7 (9.4, 14.0)  0.7 8.5  1.3 15.3  2.0 
     TOTAL 100.0 100.0   13.8 5.4 8.4  0.3 3.5  8.1 96.5  8.4 
Note: CI = confidence interval; RR = rate ratio; BT = blood transfusion; BMI = body mass index 
* Determined by the Kitagawa method, the difference between the two time periods in percentage for a given factor multiplied by the average 
blood transfusion rate for the two time periods for that factor. 
† Determined by the Kitagawa method, the difference in rates of blood transfusion between the two time periods for a given factors multiplied by 
the average percentage of that factor for the two time periods. 
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Table 10, continued. Contribution of Sociodemographic, Medical, Individual Health Service, and Hospital Health Service 
Factors to the Increase in the Rate of Blood Transfusion in Florida, 2005 and 2014 
Factor 
Birth Distribution 
 
BT Rate per 1,000 Live Births 
 Excess BT 
Attributable to 
Distributional 
Difference* 
 Excess BT 
Attributable to 
Rate 
Difference† 
 
Total 
Excess 
BT 
2014 
(%) 
2005 
(%) 
Prevalence 
Rate Difference 
(95% CI) 
 
2014 2005 
Rate Difference 
(95% CI) 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Medical Factors                
   Prepregnancy BMI (kg/m2)                
     Underweight (18.5 and less) 4.4 5.3 -0.92 (-1.06, -0.78)  14.7 6.6 8.1 (5.0, 11.2)  -0.1 -1.2  0.4 4.7  0.3 
     Normal weight (18.5-24.9) 46.8 51.8 -5.00 (-5.32, -4.68)  13.1 5.2 7.9 (7.0, 8.8)  -0.5 -5.4  3.9 46.6  3.5 
     Overweight (25-29.9) 25.6 23.6 1.93 (1.66, 2.21)  14.6 5.2 9.4 (8.1, 10.7)  0.2 2.3  2.3 27.4  2.5 
     Obese class I (30-34.9) 13.1 11.1 1.90 (1.69, 2.12)  13.8 5.8 8.0 (6.2, 9.8)  0.2 2.2  1.0 11.6  1.2 
     Obese class II (35-29.9) 6.1 4.9 1.17 (1.03, 1.32)  14.1 6.1 8.0 (5.3, 10.7)  0.1 1.4  0.4 5.2  0.6 
     Obese class III (40 and higher) 4.1 3.2 0.91 (0.78, 1.03)  14.8 5.6 9.2 (5.9, 12.6)  0.1 1.1  0.3 4.0  0.4 
     TOTAL 100.0 100.0   13.8 5.4 8.4  0.0 0.4  8.4 99.6  8.4 
   Birth Order and History of Cesarean Delivery              
     First delivery 40.6 41.9 -1.28 (-1.60, -0.96)  13.1 4.8 8.3 (7.4, 9.3)  -0.1 -1.4  3.4 41.0  3.3 
     2nd or 3rd, w/o previous cesarean 32.5 36.0 -3.51 (-3.82, -3.20)  10.1 4.2 5.8 (4.9, 6.8)  -0.3 -3.0  2.0 23.8  1.7 
     2nd or 3rd, w/ previous cesarean 16.1 12.6 3.44 (3.21, 3.66)  15.8 7.2 8.5 (6.8, 10.4)  0.4 4.7  1.2 14.6  1.6 
     4th or later, w/o  previous cesarean 7.9 7.4 0.50 (0.33, 0.67)  19.2 8.4 10.8 (8.1, 13.5)  0.1 0.8  0.8 9.8  0.9 
     4th or later, w/ previous cesarean 3.0 2.1 0.85 (0.75, 0.96)  37.6 14.8 22.8 (16.5, 29.1)  0.2 2.7  0.6 7.0  0.8 
     TOTAL 100.0 100.0   13.8 5.4 8.4  0.3 3.8  8.1 96.2  8.4 
   Plurality                
     Singleton 96.6 96.8 -0.16 (-0.27, -0.04)  12.3 5.0 7.3 (6.7, 7.9)  0.0 -0.2  7.1 84.6  7.1 
     Twin 3.3 3.1 0.20 (0.90, 3.20)  53.0 16.8 36.2 (29.7, 42.8)  0.1 0.8  1.2 13.8  1.2 
     Triplet 0.1 0.1 -0.04 (-0.07, -0.02)  142.9 42.1 100.7 (43.4, 158.0)  0.0 -0.4  0.1 1.4  0.1 
     TOTAL     19.3 11.7 7.6  0.0 0.2  8.4 99.8  8.4 
Individual Health Service Factors                
   Adequacy of Prenatal Care (GINDEX)               
     Intensive/Adequate 35.9 38.6 -2.67 (-2.98, -2.36)  13.4 4.6 8.8 (7.8, 9.8)  -0.2 0.0  3.3 39.2  3.0 
     Intermediate 37.4 34.4 3.03 (2.72, 3.34)  12.7 5.3 7.4 (6.3, 8.4)  0.3 3.2  2.6 31.5  2.9 
     Inadequate 21.1 18.1 2.99 (2.73, 3.25)  14.5 5.6 8.8 (7.4, 10.3)  0.3 3.6  1.7 20.7  2.0 
     No care 1.0 1.0 -0.03 (-0.09, 0.04)  31.1 19.8 11.3 (1.2, 21.4)  0.0 -0.1  0.1 1.4  0.1 
     Unknown 4.6 7.9 -3.32 (-3.48, -3.16)  17.8 6.8 11.1 (7.9, 14.2)  -0.4 -4.9  0.7 8.2  0.3 
     TOTAL 100.0 100.0   13.8 5.4 8.4  -0.1 -1.0  8.5 101.0  8.4 
Note: CI = confidence interval; RR = rate ratio; BT = blood transfusion; BMI = body mass index 
* Determined by the Kitagawa method, the difference between the two time periods in percentage for a given factor multiplied by the average 
blood transfusion rate for the two time periods for that factor. 
† Determined by the Kitagawa method, the difference in rates of blood transfusion between the two time periods for a given factors multiplied by 
the average percentage of that factor for the two time periods. 
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Table 10, continued. Contribution of Sociodemographic, Medical, Individual Health Service, and Hospital Health Service 
Factors to the Increase in the Rate of Blood Transfusion in Florida, 2005 and 2014 
Factor 
Birth Distribution 
 
BT Rate per 1,000 Live Births 
 Excess BT 
Attributable to 
Distributional 
Difference* 
 Excess BT 
Attributable to 
Rate 
Difference† 
 
Total 
Excess 
BT 
2014 
(%) 
2005 
(%) 
Prevalence 
Rate Difference 
(95% CI) 
 
2014 2005 
Rate Difference 
(95% CI) 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Hospital Health Service Factors                
   Level of NICU and Birth Volume Quartile               
     Level I, Bottom 5.0 6.4 -1.37 (-1.52, -1.22)  15.1 7.8 7.3 (4.3, 10.2)  -0.2 -1.9  0.4 5.0  0.3 
     Level I, Second-Third 16.2 21.2 -4.94 (-5.19, -4.69)  11.4 3.9 7.5 (6.2, 8.9)  -0.4 -4.5  1.4 16.7  1.0 
     Level I, Top 0.0 1.2 -1.21 (-1.26, -1.16)  … 0.0 …  … …  … …  … 
     Level II, Bottom 0.3 0.0 0.26 (0.24, 0.29)  6.3 …      … …  … …  … 
     Level II, Second-Third 19.0 19.1 -0.04 (-0.30, 0.21)  12.8 5.4 7.3 (5.9, 8.8)  0.0 0.0  1.4 16.7  1.4 
     Level II, Top 11.6 10.8 0.79 (0.59, 1.00)  10.2 5.1 5.1 (3.4, 6.8)  0.1 0.7  0.6 6.8  0.6 
     Level III, Second-Third 8.5 2.0 6.49 (6.35, 6.63)  13.1 6.0 7.1 (4.0, 10.2)  0.6 7.4  0.4 4.4  1.0 
     Level III, Top 39.4 39.4 0.02 (-0.34, 0.34)  16.3 6.0 10.3 (9.2, 11.4)  0.0 0.0  4.1 48.4  4.1 
     TOTAL 100.0 100.0   13.8 5.4 8.4  0.1 1.8  8.2 98.0  8.4 
   Certified Nurse Midwife Percentage Quartile              
     Bottom 52.2 48.5 3.66 (3.34, 3.99)  13.8 6.5 7.4 (6.5, 8.3)  0.4 4.4  3.7 44.2  4.1 
     Second-Third 38.3 38.9 -0.58 (-0.89, -0.26)  13.2 4.7 8.6 (7.6, 9.5)  -0.1 -0.6  3.3 39.4  3.3 
     Top 9.5 12.6 -3.08 (-3.29, -2.88)  15.5 3.3 12.2 (10.2, 14.2)  -0.3 -3.5  1.3 16.0  1.1 
     TOTAL 100.0 100.0   13.8 5.4 8.4  0.0 0.4  8.4 99.7  8.4 
   Medicaid Birth Percentage Quartile               
     Bottom 40.2 31.0 9.22 (8.91, 9.53)  11.5 4.0 7.5 (6.6, 8.5)  0.7 8.5  2.7 32.0  3.4 
     Second-Third 53.7 57.3 -3.63 (-3.95, -3.31)  13.9 4.8 9.1 (8.2, 9.9)  -0.3 -4.1  5.0 60.1  4.7 
     Top 6.1 11.7 -5.59 (-5.77, -5.41)  27.2 11.7 15.5 (12.1, 18.8)  -1.1 -12.9  1.4 16.4  0.3 
     TOTAL 100.0 100.0   13.8 5.4 8.4  -0.7 -8.5  9.1 108.5  8.4 
   Florida Geographic Location                
     Northwestern 5.3 7.5 -2.22 (-2.38, -2.06)  18.6 6.9 11.7 (8.7, 14.7)  -0.3 -3.4  0.7 8.9  0.5 
     Northeastern 12.2 11.5 0.63 (0.42, 0.83)  13.1 3.0 10.0 (8.4, 11.7)  0.1 0.6  1.2 14.2  1.2 
     Central 24.4 24.6 -0.15 (-0.43, 0.13)  11.3 5.7 5.5 (4.3, 6.8)  0.0 -0.2  1.4 16.2  1.3 
     Western 22.6 21.8 0.80 (0.53, 1.07)  12.4 3.2 9.3 (8.0, 10.5)  0.1 0.7  2.0 24.4  2.1 
     Eastern 19.7 19.8 -0.15 (-0.41, 0.11)  16.8 7.1 9.7 (8.0, 11.2)  0.0 -0.2  1.9 22.7  1.9 
     Southern 16.0 14.9 1.09 (0.86, 1.33)  14.7 6.7 8.0 (6.3, 9.7)  0.1 1.4  1.2 14.6  1.3 
     TOTAL 100.0 100.0   13.8 5.4 8.4  -0.1 -1.0  8.5 101.0  8.4 
Note: CI = confidence interval; RR = rate ratio; BT = blood transfusion; BMI = body mass index 
* Determined by the Kitagawa method, the difference between the two time periods in percentage for a given factor multiplied by the average 
blood transfusion rate for the two time periods for that factor. 
† Determined by the Kitagawa method, the difference in rates of blood transfusion between the two time periods for a given factors multiplied by 
the average percentage of that factor for the two time periods. 
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Table 11. Multivariable Decomposition of the Increase in the Rate of Severe Maternal Morbidity and Blood Transfusion in 
Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
Year          
   2014 100.0 0.0   7.08* (0.44) 8.46* (0.34)    
   2005 0.0 100.0   REF REF    
Sociodemographic Factors 
   
 
 
  
 
 
   Age 
   
 
 
  
 
 
     Younger than 20 years 5.9 10.4 -4.48  -1.87* (0.82) -0.26 (0.69)  1.10% 0.14% 
     20-34 years 78.2 75.1 3.08  REF REF  REF REF 
     35 years and older 15.9 14.5 1.41  6.09* (0.67) 2.20* (0.50)  1.13% 0.37% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  2.23%* 0.51%* 
   Race and Ethnicity 
   
 
 
  
 
 
     Non-Hispanic White 45.7 49.2 -3.48  REF REF  REF REF 
     Non-Hispanic Black 18.7 17.8 0.91  7.61* (0.67) 5.49* (0.54)  0.91% 0.60% 
     Hispanic 31.1 28.8 2.26  1.50* (0.52) 1.15* (0.41)  0.45% 0.31% 
     Other 4.5 4.2 0.30  2.51* (1.02) 1.45* (0.77)  0.10% 0.05% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  1.46%* 0.96%* 
   Education 
   
 
 
  
 
 
     Less than high school 12.5 19.1 -6.52  2.29* (0.73) 1.93* (0.60)  -1.96% -1.50% 
     High school graduate or GED 32.2 32.0 0.20  0.66 (0.50) 0.93* (0.40)  0.02% 0.02% 
     Some college or greater 55.3 49.0 6.32  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -1.95%* -1.48%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions. 
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Table 11, continued. Multivariable Decomposition of the Increase in the Rate of Severe Maternal Morbidity and Blood 
Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
   Insurance Status 
   
 
 
  
 
 
     Medicaid 53.0 46.4 6.53  1.62* (0.49) 2.15* (0.39)  1.39% 1.67% 
     Private 44.0 48.2 -4.21  REF REF  REF REF 
     Self-pay 2.3 4.0 -1.67  -2.94* (1.03) -0.92 (0.80)  0.65% 0.18% 
     Other 0.7 1.4 -0.64  3.61* (2.21) 3.92* (1.80)  -0.30% -0.30% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  1.74%* 1.56%* 
   Father Acknowledged on Birth Certificate 
   
 
 
  
 
 
     Yes 86.7 91.4 -4.75  REF REF  REF REF 
     No 13.3 8.6 4.75  3.25* (0.79) 2.94* (0.67)  2.03% 1.67% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  2.03%* 1.67%* 
Medical Factors 
   
 
 
  
 
 
   Prepregnancy BMI (kg/m2) 
   
 
 
  
 
 
     Underweight (18.5 and less) 4.4 5.3 -0.92  1.40 (0.97) 1.34 (0.78)  -0.17% -0.15% 
     Normal weight (18.5–24.9) 46.8 51.8 -5.00  REF REF  REF REF 
     Overweight (25–29.9) 25.6 23.6 1.93  -0.12 (0.51) -0.19 (0.40)  -0.03% -0.04% 
     Obese class I (30–34.9) 13.1 11.2 1.90  -0.92 (0.67) -1.10* (0.53)  -0.23% -0.25% 
     Obese class II (35-39.9) 6.1 4.9 1.17  -0.28 (0.98) -1.33 (0.76)  -0.04% -0.19% 
     Obese class III (40 and greater) 4.1 3.2 0.91  -2.08 (1.18) -1.96* (0.93)  -0.25% -0.21% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -0.72% -0.84%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions. 
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Table 11, continued. Multivariable Decomposition of the Increase in the Rate of Severe Maternal Morbidity and Blood 
Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
   Birth Order and History of Cesarean 
Delivery    
 
 
 
 
 
 
     First delivery 40.6 41.9 -1.28  5.19* (0.44) 2.91* (0.35)  -0.87% -0.44% 
     2nd or 3rd, w/o previous cesarean 32.5 36.0 -3.51  REF REF  REF REF 
     2nd or 3rd, w/ previous cesarean 16.1 12.6 3.44  9.74* (0.70) 5.02* (0.54)  4.41% 2.06% 
     4th or later, w/o  previous cesarean 7.9 7.4 0.50  4.52* (0.90) 3.73* (0.74)  0.30% 0.22% 
     4th or later, w/ previous cesarean 3.0 2.1 0.85  23.73* (2.04) 17.32* (1.71)  2.66% 1.76% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  6.49%* 3.59%* 
   Plurality 
   
 
 
  
 
 
     Singleton 96.6 96.8 -0.16  REF REF  REF REF 
     Twin 3.3 3.1 0.20  36.46* (2.06) 26.49* (1.71)  0.96% 0.63% 
     Triplet 0.1 0.1 -0.04  87.58* (14.58) 74.92* (13.15)  -0.46% -0.36% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  0.50%* 0.27%* 
Individual Health Service Factors 
   
 
 
  
 
 
   Adequacy of Prenatal Care GINDEX 
   
 
 
  
 
 
     Intensive/Adequate 35.9 38.6 -2.67  REF REF  REF REF 
     Intermediate 37.4 34.4 3.03  -1.57* (0.47) -0.34 (0.37)  -0.63% -0.12% 
     Inadequate 21.1 18.1 2.99  -1.83* (0.58) -0.11 (0.46)  -0.72% -0.04% 
     No care 1.0 1.0 -0.03  14.33* (2.98) 11.73* (2.57)  -0.06% -0.04% 
     Unknown 4.6 7.9 -3.32  1.56 (0.94) 1.61* (0.73)  -0.68% -0.64% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -2.09%* -0.84%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions. 
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Table 11, continued. Multivariable Decomposition of the Increase in the Rate of Severe Maternal Morbidity and Blood 
Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
Hospital Health Service Factors 
   
 
 
  
 
 
   Level of NICU and Birth Volume Quartile 
   
 
 
  
 
 
     Level I, Bottom 5.0 6.4 -1.37  -2.32* (0.94) 0.19 (0.78)  0.42% -0.03% 
     Level I, Second-Third 16.2 21.2 -4.94  -5.71* (0.57) -2.13* (0.46)  3.71% 1.26% 
     Level I, Top 0.0 1.2 -1.21  -3.93 (2.24) -7.08* (0.94)  0.63% 1.02% 
     Level II, Bottom 0.3 0.0 0.26  -11.86* (4.24) -8.06* (3.66)  -0.41% -0.25% 
     Level II, Second-Third 19.0 19.1 -0.04  -3.75* (0.59) -1.12* (0.47)  0.02% 0.01% 
     Level II, Top 11.6 10.8 0.79  -3.95* (0.68) -0.78* (0.54)  -0.41% -0.07% 
     Level III, Second-Third 8.5 2.0 6.49  -1.61 (1.10) -1.48 (0.86)  -1.38% -1.14% 
     Level III, Top 39.4 39.4 0.02  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  2.58%* 0.78%* 
   Percentage of Deliveries to Certified Nurse Midwives Quartile 
 
  
 
 
     Bottom 52.2 48.5 3.66  0.50 (0.73) 0.00 (0.58)  0.24% 0.00% 
     Second-Third 38.3 38.9 -0.58  -0.22 (0.71) -0.28 (0.56)  0.02% 0.02% 
     Top 9.5 12.6 -3.08  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  0.26% 0.02% 
   Medicaid Birth Percentage Quartile 
   
 
 
  
 
 
     Bottom 33.8 26.1 7.67  REF REF  REF REF 
     Second-Third 51.1 56.6 -5.54  0.20 (0.49) 0.23 (0.38)  -0.15% -0.15% 
     Top 15.2 17.3 -2.13  8.30* (0.97) 8.28* (0.81)  -2.33% -2.10% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -2.48%* -2.26%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions. 
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Table 11, continued. Multivariable Decomposition of the Increase in the Rate of Severe Maternal Morbidity and Blood 
Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
   Florida Geographic Location 
   
 
 
  
 
 
     Northwestern 5.3 7.5 -2.22  3.71* (1.01) 4.31* (0.85)  -1.08% -1.14% 
     Northeastern 12.2 11.5 0.63  0.17 (0.70) -1.83* (0.54)  0.01% -0.14% 
     Central 24.4 24.6 -0.15  REF REF  REF REF 
     Western 22.6 21.8 0.80  0.89 (0.61) -1.10* (0.47)  0.09% -0.11% 
     Eastern 19.7 19.8 -0.15  3.25* (0.67) 2.60* (0.55)  -0.06% -0.05% 
     Southern 16.0 14.9 1.09  0.77 (0.72) -0.08 (0.58)  0.11% -0.01% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -0.93%* -1.44%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions. 
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Table 12. Contribution of Mode of Delivery, Diabetes, and Hypertension to the Increase in the Rate of Severe Maternal 
Morbidity in Florida, 2005 and 2014 
Factors 
Birth Distribution 
 
SMM Rate per 1,000 Live Births 
 Excess SMM 
Attributable to 
Distributional 
Difference* 
 
Excess SMM 
Attributable to 
Rate Difference† 
 
Total 
Excess 
SMM 
2014 
(%) 
2005 
(%) 
Prevalence 
Rate Difference 
(95% CI) 
 
2014 2005 
Rate Difference 
(95% CI) 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Severe Maternal Morbidity 100.0 100.0   19.3 11.7 7.6 (6.8, 8.4)         
   Mode of Delivery                
     Cesarean delivery 39.9 36.7 3.22 (2.90, 3.53)  34.6 23.4 11.2 (9.5, 13.0)  0.9 12.4  4.3 57.2  5.2 
     Vaginal delivery 60.1 63.3 -3.22 (-3.53, -2.90)  9.1 4.9 4.2 (3.5, 4.9)  -0.2 -3.0  -3.0 34.5  2.4 
     TOTAL 100.0 100.0   19.3 11.7   0.7 0.7  9.3 90.7  7.6 
   Diabetes                
     Diabetes 8.7 6.5 2.14 (1.97, 2.31)  26.2 17.1 9.1 (5.7, 12.5)  0.5 6.1  0.7 9.1  1.2 
     No diabetes 91.4 93.5 -2.14 (-2.31, 1.97)  18.7 11.3 7.3 (6.5, 8.1)  -0.3 -4.2  6.8 89.0  6.4 
     TOTAL 100.0 100.0   19.3 11.7   0.1 1.9  7.5 98.1  7.6 
   Hypertension                
     Hypertension 10.2 9.1 1.07 (0.88, 1.26)  36.1 24.9 11.2 (7.6, 14.8)  0.3 2.8  1.1 9.4  1.4 
     No Hypertension 89.8 90.9 -1.07 (-1.26, -0.88)  17.4 10.4 7.0 (6.2, 7.8)  -0.1 -1.3  6.3 55.1  6.2 
     TOTAL 100.0 100.0   19.3 11.7   0.2 2.3  7.4 97.7  7.6 
Note: CI = confidence interval; RR = rate ratio; SMM = severe maternal morbidity 
* Determined by the Kitagawa method, the difference between the two time periods in percentage for a given factor multiplied by the average severe maternal 
morbidity rate for the two time periods for that factor. 
† Determined by the Kitagawa method, the difference in rates of severe maternal morbidity between the two time periods for a given factors multiplied by the 
average percentage of that factor for the two time periods.
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Table 13. Contribution of Mode of Delivery, Diabetes, and Hypertension to the Increase in the Rate of Blood Transfusions in 
Florida, 2005 and 2014 
Factors 
Birth Distribution 
 
BT Rate per 1,000 Live Births 
 Excess BT 
Attributable to 
Distributional 
Difference* 
 
Excess BT 
Attributable to 
Rate Difference† 
 
Total 
Excess 
BT 
2014 
(%) 
2005 
(%) 
Prevalence 
Rate Difference 
(95% CI) 
 
2014 2005 
Rate Difference 
(95% CI) 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Total 
% 
 
N 
1,000 
Blood Transfusions 100.0 100.0   13.8 5.4 8.4 (7.8, 9.0)         
   Mode of Delivery                
     Cesarean delivery 39.9 36.7 3.22 (2.90, 3.53)  24.0 10.0 14.0 (12.7, 15.4)  0.5 7.4  5.4 73.0  5.9 
     Vaginal delivery 60.1 63.3 -3.22 (-3.53, -2.90)  7.0 2.7 4.3 (3.7, 4.8)  -.02 -2.1  -2.1 35.8  2.5 
     TOTAL 100.0 100.0   13.8 5.4   0.4 4.7  4.7 95.3  8.4 
   Diabetes                
     Diabetes 8.7 6.5 2.14 (1.97, 2.31)  16.8 7.2 9.5 (7.0, 12.1)  0.3 0.3  3.1 8.6  1.0 
     No diabetes 91.4 93.5 -2.14 (-2.31, 1.97)  13.5 5.2 8.2 (6.5, 8.1)  -0.2 -0.2  -2,4 90.7  7.4 
     TOTAL 100.0 100.0   13.8 5.4   0.1 0.1  0.7 99.3  8.4 
   Hypertension                
     Hypertension 10.2 9.1 1.07 (0.88, 1.26)  25.7 11.7 14.1 (11.3, 16.9)  0.2 0.2  1.6 11.1  1.6 
     No Hypertension 89.8 90.9 -1.07 (-1.26, -0.88)  12.4 4.7 7.7 (7.0, 8.3)  -0.1 -0.1  -0.8 56.9  6.8 
     TOTAL 100.0 100.0   13.8 5.4   0.1 0.1  1.3 98.7  8.4 
Note: CI = confidence interval; RR = rate ratio; BT = blood transfusion 
* Determined by the Kitagawa method, the difference between the two time periods in percentage for a given factor multiplied by the average blood transfusion 
rate for the two time periods for that factor. 
† Determined by the Kitagawa method, the difference in rates of blood transfusion between the two time periods for a given factors multiplied by the average 
percentage of that factor for the two time periods.
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Table 14. Sensitivity Analysis Including Mode of Delivery: Multivariable Decomposition of the Increase in the Rate of Severe 
Maternal Morbidity and Blood Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
Year          
   2014 100.0 0.0   7.47* (0.43) 8.62* (0.34)    
   2005 0.0 100.0   REF REF    
Sociodemographic Factors 
   
 
 
  
 
 
   Age 
   
 
 
  
 
 
     Younger than 20 years 5.9 10.4 -4.48  0.23 (0.82) 0.89 (0.69)  -0.14% -0.48% 
     20-34 years 78.2 75.1 3.08  REF REF  REF REF 
     35 years and older 15.9 14.5 1.41  4.04* (0.67) 1.09* (0.50)  0.75% 0.18% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  0.61%* -0.29%* 
   Race and Ethnicity 
   
 
 
  
 
 
     Non-Hispanic White 45.7 49.2 -3.48  REF REF  REF REF 
     Non-Hispanic Black 18.7 17.8 0.91  7.46* (0.67) 5.41* (0.53)  0.89% 0.59% 
     Hispanic 31.1 28.8 2.26  1.07* (0.52) 0.92* (0.41)  0.32% 0.25% 
     Other 4.5 4.2 0.30  2.29* (1.02) 1.34 (0.77)  0.09% 0.05% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  1.30%* 0.88%* 
   Education 
   
 
 
  
 
 
     Less than high school 12.5 19.1 -6.52  2.44* (0.73) 2.01* (0.60)  -2.10% -1.56% 
     High school graduate or GED 32.2 32.0 0.20  0.60 (0.50) 0.90* (0.40)  0.02% 0.02% 
     Some college or greater 55.3 49.0 6.32  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -2.08%* -1.54%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions
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Table 14, continued. Sensitivity Analysis Including Mode of Delivery: Multivariable Decomposition of the Increase in the Rate 
of Severe Maternal Morbidity and Blood Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
   Insurance Status 
   
 
 
  
 
 
     Medicaid 53.0 46.4 6.53  1.68* (0.49) 2.18* (0.39)  1.45% 1.70% 
     Private 44.0 48.2 -4.21  REF REF  REF REF 
     Self-pay 2.3 4.0 -1.67  -1.85* (1.03) -0.33 (0.80)  0.41% 0.07% 
     Other 0.7 1.4 -0.64  4.20 (2.21) 4.24* (1.80)  -0.35% -0.32% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  1.50%* 1.44%* 
   Father Acknowledged on Birth Certificate 
   
 
 
  
 
 
     Yes 86.7 91.4 -4.75  REF REF  REF REF 
     No 13.3 8.6 4.75  3.07* (0.79) 2.84* (0.67)  1.92% 1.61% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  1.92%* 1.61%* 
Medical Factors 
   
 
 
  
 
 
   Mode of Delivery 
   
 
 
  
 
 
     Cesarean Delivery 39.9 36.7 3.22  23.35* (0.67) 12.75* (0.52)  9.90% 4.90% 
     Vaginal Delivery 60.1 63.3 -3.22  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  9.90%* 4.90%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions.
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Table 14, continued. Sensitivity Analysis Including Mode of Delivery: Multivariable Decomposition of the Increase in the Rate 
of Severe Maternal Morbidity and Blood Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
   Prepregnancy BMI (kg/m2) 
   
 
 
  
 
 
     Underweight (18.5 and less) 4.4 5.3 -0.92  2.20* (0.96) 1.77* (0.78)  -0.27% -0.19% 
     Normal weight (18.5–24.9) 46.8 51.8 -5.00  REF REF  REF REF 
     Overweight (25–29.9) 25.6 23.6 1.93  -1.30* (0.51) -0.84* (0.40)  -0.33% -0.19% 
     Obese class I (30–34.9) 13.1 11.2 1.90  -2.96* (0.67) -2.21* (0.53)  -0.74% -0.50% 
     Obese class II (35-39.9) 6.1 4.9 1.17  -3.13* (0.99) -2.89* (0.76)  -0.48% -0.40% 
     Obese class III (40 and greater) 4.1 3.2 0.91  -5.96* (1.19) -4.08* (0.94)  -0.71% -0.44% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -2.54%* -1.74%* 
   Birth Order and History 
   
 
 
  
 
 
     First delivery 40.6 41.9 -1.28  -0.41* (0.47) -0.15 (0.37)  0.07% 0.02% 
     2nd or 3rd, w/o previous cesarean 32.5 36.0 -3.51  REF REF  REF REF 
     2nd or 3rd, w/ previous cesarean 16.1 12.6 3.44  -8.38* (0.93) 4.88* (0.72)  -3.80% -2.00% 
     4th or later, w/o  previous cesarean 7.9 7.4 0.50  5.18* (0.89) 4.09* (0.74)  0.34% 0.24% 
     4th or later, w/ previous cesarean 3.0 2.1 0.85  7.84* (2.11) 8.64* (1.76)  0.88% 0.88% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -2.51%* -0.86%* 
   Plurality 
   
 
 
  
 
 
     Singleton 96.6 96.8 -0.16  REF REF  REF REF 
     Twin 3.3 3.1 0.20  24.90* (2.08) 20.18* (1.73)  0.66% 0.48% 
     Triplet 0.1 0.1 -0.04  72.37* (14.57) 66.61* (13.14)  -0.38% -0.32% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  0.27%* 0.16%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions
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Table 14, continued. Sensitivity Analysis Including Mode of Delivery: Multivariable Decomposition of the Increase in the Rate 
of Severe Maternal Morbidity and Blood Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
Individual Health Service Factors 
   
 
 
  
 
 
   Adequacy of Prenatal Care GINDEX 
   
 
 
  
 
 
     Intensive/Adequate 35.9 38.6 -2.67  REF REF  REF REF 
     Intermediate 37.4 34.4 3.03  -1.16* (0.47) -0.12 (0.37)  -0.46% -0.04% 
     Inadequate 21.1 18.1 2.99  -1.35* (0.58) 0.15 (0.46)  -0.53% 0.05% 
     No care 1.0 1.0 -0.03  14.78* (2.97) 11.98* (2.56)  -0.06% -0.04% 
     Unknown 4.6 7.9 -3.32  1.79 (0.93) 1.74* (0.73)  -0.78% -0.69% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -1.84%* -0.72%* 
Hospital Health Service Factors 
   
 
 
  
 
 
   Level of NICU and Birth Volume Quartile 
   
 
 
  
 
 
     Level I, Bottom 5.0 6.4 -1.37  -2.12* (0.94) 0.30 (0.78)  0.38% -0.05% 
     Level I, Second-Third 16.2 21.2 -4.94  -5.40* (0.56) -1.96* (0.46)  3.51% 1.16% 
     Level I, Top 0.0 1.2 -1.21  -4.92 (2.23) -7.62* (0.95)  0.78% 1.10% 
     Level II, Bottom 0.3 0.0 0.26  -11.25* (4.24) -7.72* (3.65)  -0.39% -0.24% 
     Level II, Second-Third 19.0 19.1 -0.04  -3.57* (0.59) -1.02* (0.47)  0.02% 0.00% 
     Level II, Top 11.6 10.8 0.79  -3.37* (0.68) -0.47 (0.54)  -0.35% -0.04% 
     Level III, Second-Third 8.5 2.0 6.49  -1.51 (1.09) -1.42 (0.86)  -1.29% -1.10% 
     Level III, Top 39.4 39.4 0.02  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  2.67%* 0.83%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions
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Table 14, continued. Sensitivity Analysis Including Mode of Delivery: Multivariable Decomposition of the Increase in the Rate 
of Severe Maternal Morbidity and Blood Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
   Percentage of Deliveries to Certified Nurse Midwives Quartile  
 
  
 
 
     Bottom 52.2 48.5 3.66  -0.26 (0.73) -0.42 (0.58)  -0.13% -0.18% 
     Second-Third 38.3 38.9 -0.58  -0.70 (0.71) -0.54 (0.56)  0.05% 0.04% 
     Top 9.5 12.6 -3.08  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0   
 
  -0.07% -0.15% 
   Medicaid Birth Percentage Quartile          
     Bottom 33.8 26.1 7.67  REF REF  REF REF 
     Second-Third 51.1 56.6 -5.54  0.27 (0.49) 0.27 (0.38)  -0.19% -0.18% 
     Top 15.2 17.3 -2.13  8.31* (0.96) 8.29* (0.81)  -2.33% -2.10% 
     TOTAL EXPLAINED 100.0 100.0      -2.52%* -2.28%* 
   Florida Geographic Location 
   
 
 
  
 
 
     Northwestern 5.3 7.5 -2.22  4.38* (1.01) 4.67* (0.85)  -1.28% -1.24% 
     Northeastern 12.2 11.5 0.63  0.64 (0.70) -1.58* (0.54)  0.05% -0.12% 
     Central 24.4 24.6 -0.15  REF REF  REF REF 
     Western 22.6 21.8 0.80  1.02 (0.60) -1.03* (0.47)  0.11% -0.10% 
     Eastern 19.7 19.8 -0.15  2.66* (0.67) 2.28* (0.55)  -0.05% -0.04% 
     Southern 16.0 14.9 1.09  -0.64 (0.72) -0.85 (0.58)  -0.09% -0.11% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -1.26%* -1.60%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions.
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Table 15. Sensitivity Analysis Including Diabetes and Hypertension: Multivariable Decomposition of the Increase in the Rate 
of Severe Maternal Morbidity and Blood Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
Year          
   2014 100.0 0.0   7.01* (0.43) 8.36* (0.34)    
   2005 0.0 100.0   REF REF    
Sociodemographic Factors 
   
 
 
  
 
 
   Age 
   
 
 
  
 
 
     Younger than 20 years 5.9 10.4 -4.48  -1.70* (0.82) -0.18 (0.69)  1.01% 0.09% 
     20-34 years 78.2 75.1 3.08  REF REF  REF REF 
     35 years and older 15.9 14.5 1.41  5.25* (0.67) 1.73* (0.50)  0.98% 0.29% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  1.98%* 0.39%* 
   Race and Ethnicity 
   
 
 
  
 
 
     Non-Hispanic White 45.7 49.2 -3.48  REF REF  REF REF 
     Non-Hispanic Black 18.7 17.8 0.91  7.41* (0.67) 5.35* (0.53)  0.89% 0.58% 
     Hispanic 31.1 28.8 2.26  1.70* (0.52) 1.29* (0.41)  0.51% 0.35% 
     Other 4.5 4.2 0.30  2.59* (1.02) 1.56* (0.77)  0.10% 0.06% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  1.50%* 0.98%* 
   Education 
   
 
 
  
 
 
     Less than high school 12.5 19.1 -6.52  2.25* (0.73) 1.91* (0.60)  -1.93% -1.48% 
     High school graduate or GED 32.2 32.0 0.20  0.60 (0.50) 0.89* (0.40)  0.02% 0.02% 
     Some college or greater 55.3 49.0 6.32  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -1.92%* -1.46%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions.
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Table 15, continued. Sensitivity Analysis Including Diabetes and Hypertension: Multivariable Decomposition of the Increase 
in the Rate of Severe Maternal Morbidity and Blood Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
   Insurance Status 
   
 
 
  
 
 
     Medicaid 53.0 46.4 6.53  1.69* (0.49) 2.19* (0.39)  1.45% 1.71% 
     Private 44.0 48.2 -4.21  REF REF  REF REF 
     Self-pay 2.3 4.0 -1.67  -2.66* (1.02) -0.75 (0.80)  0.59% 0.15% 
     Other 0.7 1.4 -0.64  3.50 (2.21) 3.85* (1.80)  -0.29% -0.29% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  1.74%* 1.56%* 
   Father Acknowledged on Birth Certificate 
   
 
 
  
 
 
     Yes 86.7 91.4 -4.75  REF REF  REF REF 
     No 13.3 8.6 4.75  3.25* (0.79) 2.93* (0.67)  2.03% 1.66% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  2.03%* 1.66%* 
Medical Factors 
   
 
 
  
 
 
   Diabetes 
   
 
 
  
 
 
     Diabetes 8.7 6.5 2.14  3.93* (0.92) 1.60* (0.70)  1.11% 4.90% 
     No Diabetes 91.4 93.5 -2.14  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  1.11%* 4.90%* 
   Hypertension 
   
 
 
  
 
 
     Hypertension 10.2 9.1 1.07  14.61* (0.96) 9.29* (0.76)  2.06% 4.90% 
     No Hypertension 89.8 90,9 -1.07  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  2.06%* 4.90%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions.
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Table 15, continued. Sensitivity Analysis Including Diabetes and Hypertension: Multivariable Decomposition of the Increase 
in the Rate of Severe Maternal Morbidity and Blood Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
   Prepregnancy BMI (kg/m2) 
   
 
 
  
 
 
     Underweight (18.5 and less) 4.4 5.3 -0.92  1.64* (0.97) 1.48 (0.78)  -0.20% -0.16% 
     Normal weight (18.5–24.9) 46.8 51.8 -5.00  REF REF  REF REF 
     Overweight (25–29.9) 25.6 23.6 1.93  -0.88* (0.51) -0.64 (0.40)  -0.22% -0.15% 
     Obese class I (30–34.9) 13.1 11.2 1.90  -2.51* (0.68) -2.04* (0.54)  -0.63% -0.46% 
     Obese class II (35-39.9) 6.1 4.9 1.17  -2.70* (1.00) -2.78* (0.77)  -0.42% -0.39% 
     Obese class III (40 and greater) 4.1 3.2 0.91  -5.66* (1.20) -4.10* (0.95)  -0.68% -0.44% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -2.15%* -1.61%* 
   Birth Order and History 
   
 
 
  
 
 
     First delivery 40.6 41.9 -1.28  4.44* (0.44) 2.44  (0.35)  -0.75% -0.37% 
     2nd or 3rd, w/o previous cesarean 32.5 36.0 -3.51  REF REF  REF REF 
     2nd or 3rd, w/ previous cesarean 16.1 12.6 3.44  -9.69* (0.70) 5.00* (0.54)  -4.39% -2.05% 
     4th or later, w/o  previous cesarean 7.9 7.4 0.50  4.53* (0.90) 3.74* (0.74)  0.30% 0.22% 
     4th or later, w/ previous cesarean 3.0 2.1 0.85  23.66* (2.04) 17.29* (1.71)  2.65% 1.75% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -6.59%* 3.66%* 
   Plurality 
   
 
 
  
 
 
     Singleton 96.6 96.8 -0.16  REF REF  REF REF 
     Twin 3.3 3.1 0.20  35.33* (2.06) 25.78* (1.71)  0.93% 0.61% 
     Triplet 0.1 0.1 -0.04  86.26* (14.58) 74.08* (13.15)  -0.45% -0.35% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  0.48%* 0.26%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions.
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Table 15, continued. Sensitivity Analysis Including Diabetes and Hypertension: Multivariable Decomposition of the Increase 
in the Rate of Severe Maternal Morbidity and Blood Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
Individual Health Service Factors 
   
 
 
  
 
 
   Adequacy of Prenatal Care GINDEX 
   
 
 
  
 
 
     Intensive/Adequate 35.9 38.6 -2.67  REF REF  REF REF 
     Intermediate 37.4 34.4 3.03  -1.08* (0.48) -0.05 (0.37)  -0.43% -0.02% 
     Inadequate 21.1 18.1 2.99  -1.34* (0.58) 0.18 (0.47)  -0.53% 0.06% 
     No care 1.0 1.0 -0.03  14.67* (2.97) 11.90* (2.57)  -0.06% -0.04% 
     Unknown 4.6 7.9 -3.32  1.84 (0.93) 1.77* (0.73)  -0.80% -0.70% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -1.82%* -0.70%* 
Hospital Health Service Factors 
   
 
 
  
 
 
   Level of NICU and Birth Volume Quartile 
   
 
 
  
 
 
     Level I, Bottom 5.0 6.4 -1.37  -2.01* (0.94) 0.36 (0.78)  0.36% -0.06% 
     Level I, Second-Third 16.2 21.2 -4.94  -5.30* (0.56) -1.89* (0.46)  3.45% 1.11% 
     Level I, Top 0.0 1.2 -1.21  -5.54 (2.24) -8.09* (0.95)  0.88% 1.17% 
     Level II, Bottom 0.3 0.0 0.26  -12.11* (4.24) -8.23* (3.65)  -0.41% -0.26% 
     Level II, Second-Third 19.0 19.1 -0.04  -3.32* (0.59) -0.86 (0.47)  0.02% 0.00% 
     Level II, Top 11.6 10.8 0.79  -3.62* (0.68) -0.59 (0.54)  -0.38% -0.06% 
     Level III, Second-Third 8.5 2.0 6.49  -1.48 (1.10) -1.41 (0.86)  -1.27% -1.09% 
     Level III, Top 39.4 39.4 0.02  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  2.65%* 0.82%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions.
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Table 15, continued. Sensitivity Analysis Including Diabetes and Hypertension: Multivariable Decomposition of the Increase 
in the Rate of Severe Maternal Morbidity and Blood Transfusion in Florida, 2005 and 2014 
Factors 
Covariate Distribution† 
 Adjusted Linear Parameter Estimates, 
Deaths/1,000 Live Births 
 Disparity Explained by Covariate 
Distributional Differences 
2014 
% 
2005 
% 
Prevalence 
Rate 
Difference 
 
SMM, 
b (SE) 
Blood 
Transfusions, 
b (SE) 
 
SMM, % 
Blood 
Transfusions, 
% 
   Certified Nurse Midwife Percentage Quartile 
   
 
 
  
 
 
     Bottom 52.2 48.5 3.66  0.51 (0.73) 0.01 (0.58)  0.25% 0.01% 
     Second-Third 38.3 38.9 -0.58  -0.13 (0.71) -0.22 (0.56)  0.01% 0.02% 
     Top 9.5 12.6 -3.08  REF REF  REF REF 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  0.26% 0.02% 
   Medicaid Birth Percentage Quartile 
   
 
 
  
 
 
     Bottom 33.8 26.1 7.67  REF REF  REF REF 
     Second-Third 51.1 56.6 -5.54  0.04 (0.49) 0.14 (0.38)  -0.03% -0.09% 
     Top 15.2 17.3 -2.13  8.06* (0.97) 8.13* (0.81)  -2.26% -2.07% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -2.29%* -2.16%* 
   Florida Geographic Location 
   
 
 
  
 
 
     Northwestern 5.3 7.5 -2.22  3.47* (1.01) 4.15* (0.85)  -1.01% -1.20% 
     Northeastern 12.2 11.5 0.63  -0.03 (0.70) -1.95* (0.54)  0.00% -0.15% 
     Central 24.4 24.6 -0.15  REF REF  REF REF 
     Western 22.6 21.8 0.80  1.06 (0.60) -0.99* (0.47)  0.11% -0.09% 
     Eastern 19.7 19.8 -0.15  3.35* (0.67) 2.67* (0.55)  -0.07% -0.05% 
     Southern 16.0 14.9 1.09  1.07 (0.72) 0.09 (0.58)  0.15% 0.01% 
     TOTAL EXPLAINED 100.0 100.0 
 
 
 
  -0.82%* -1.38%* 
Note: SMM = severe maternal morbidity; BMI = body mass index 
* P < 0.05. 
† All covariates differed significantly by year as determined by the χ2 test: P < 0.001. 
§ Obtained from Oaxaca decomposition derived from adjusted coefficients multiplied by covariate distributional differences (summed over multiple category 
variables). Positive numbers indicate a disadvantage in 2014 that helps to explain the increase in severe maternal morbidity and blood transfusions. 
86 
 
FIGURES 
 
Figure 1. Rates of Severe Maternal Morbidity in Florida, 2005-2014. 
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Figure 2. Rates of Obstetric Hemorrhage-Related Complications in Florida, 2005-2014. 
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